FATTY LIVER INSULIN RESISTANCE
March 28, 2024EXERCISE PROTECTS
March 28, 2024- The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis
- obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised …
- obesity and nonalcoholic fatty liver disease
- Abdominal obesity and fatty liver
- obesity and nonalcoholic fatty liver disease: current perspectives
- obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
- fatty liver disease in morbid obesity
- Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations
- obesity, fatty liver and liver cancer.
- obesity is an independent risk factor for non‐alcoholic fatty liver disease: evidence from a meta‐analysis of 21 cohort studies
- liver cancer: connections with obesity, fatty liver, and cirrhosis
- Non-alcoholic fatty liver disease, obesity and the metabolic syndrome
- Efficacy of dietary intervention and physical activity in children and adolescents with nonalcoholic fatty liver disease associated with obesity: A scoping review
- Prevalence of nonalcoholic fatty liver disease in children with obesity
- obesity and the liver: nonalcoholic fatty liver disease
- Prevalence of fatty liver in Japanese children and relationship to obesity: an epidemiological ultrasonographic survey
- Nonalcoholic fatty liver disease and obesity treatment
- Alcohol and obesity: a dangerous association for fatty liver disease
- The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity
- obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer
- … impact of two personalized dietary strategies in subjects with obesity and nonalcoholic fatty liver disease: the fatty liver in obesity (FLiO) randomized controlled …
- Arterial hypertension, obesity and non-alcoholic fatty liver disease: is there any connection?
- Metabolically healthy obesity and the development of nonalcoholic fatty liver disease
- fatty liver and its fibrous changes found in simple obesity of children
- Drug-induced liver injury in obesity and nonalcoholic fatty liver disease
- Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index
- Evaluation and management of obesity-related nonalcoholic fatty liver disease
- Macronutrients and the adipose-liver axis in obesity and fatty liver
- obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease
- fatty liver disease: is it nonalcoholic fatty liver disease or obesity-associated fatty liver disease?
- Nonalcoholic fatty liver disease and obesity
- Early obesity: risk factor for fatty liver disease
- … complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease
- fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors
- Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome
- Nonalcoholic fatty liver disease and obesity
- Drinking and obesity: alcoholic liver disease/nonalcoholic fatty liver disease interactions
- Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease
- The intersection of nonalcoholic fatty liver disease and obesity
- Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity
- obesity-associated nonalcoholic fatty liver disease
- Nonalcoholic fatty liver disease, diabetes, obesity, and hepatocellular carcinoma
- Acetaminophen‐induced liver injury in obesity and nonalcoholic fatty liver disease
- obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression
- Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease
- Adipose tissue, obesity and non-alcoholic fatty liver disease.
- Pediatric fatty liver and obesity: not always just a matter of non-alcoholic fatty liver disease
- Association between different animal protein sources and liver status in obese subjects with non-alcoholic fatty liver disease: fatty liver in obesity (FLiO) study
- Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol-and obesity-induced fatty liver diseases
- Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease
- liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity
- Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes
- obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
- obesity, fatty liver disease and intestinal microbiota
- Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
- Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery
- What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?
- Nonalcoholic fatty liver disease in individuals with severe obesity
- The differential roles of T cells in non-alcoholic fatty liver disease and obesity
- Non-alcoholic fatty liver disease and childhood obesity
- The obesity epidemic and nonalcoholic fatty liver disease in children
- Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic obesity Study
- Non-alcoholic fatty liver disease (NAFLD) in obesity
- Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
- Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance
- Nonalcoholic fatty liver disease and the epidemic of obesity
- Molecular mechanisms of fatty liver in obesity
- Nonalcoholic fatty liver: the association with metabolic abnormalities, body mass index and central obesity—a population-based study
- The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity–a longitudinal cohort study
- Non-alcoholic fatty liver disease and its relationship with the nutritional status of vitamin A in individuals with class III obesity
- Non-alcoholic fatty liver disease and obesity: not all about body mass index
- Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity
- Severe obesity is associated with liver disease severity in pediatric non‐alcoholic fatty liver disease
- Sarcopenic obesity in fatty liver
- Visceral obesity predicts significant fibrosis in patients with nonalcoholic fatty liver disease
- liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance
- obesity and non-alcoholic fatty liver disease in chronic hepatitis C
- Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease
- The impact of nonalcoholic fatty liver disease on renal function in children with overweight/obesity
- Nonalcoholic fatty liver disease relationship with metabolic syndrome in class III obesity individuals
- The potential role of prebiotic fibre for treatment and management of non‐alcoholic fatty liver disease and associated obesity and insulin resistance
- Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity: a meta-analysis
- Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria
- Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity
- obesity, visceral fat, and NAFLD: querying the role of adipokines in the progression of nonalcoholic fatty liver disease
- Benefits of exenatide on obesity and non‐alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes
- Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity
- Thyroid function and the risk of non-alcoholic fatty liver disease in morbid obesity
- Increased prevalence of obesity and metabolic syndrome in patients with alcoholic fatty liver disease
- obesity and nonalcoholic fatty liver disease: role of oxidative stress
- Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice
- Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease
- obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound
- CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease
- Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease
- Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat
- The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease
- Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys …
- Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications
- obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations
- Nonalcoholic fatty liver disease is associated with hyperlipidemia and obesity
- The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity
- Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in …
- Association of short sleep duration with obesity, diabetes, fatty liver and behavioral factors in Japanese men
- The relationship between serum transaminase activities and fatty liver in children with simple obesity
- Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium
- obesity and weight gain are associated with progression of fibrosis in patients with nonalcoholic fatty liver disease
- Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists
- Misregulation of PPAR functioning and its pathogenic consequences associated with nonalcoholic fatty liver disease in human obesity
- Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance
- Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?
- Non‐alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C‐reactive protein in Hispanics
- Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease [S]
- Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK
- Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic fatty liver disease
- Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease
- Nonalcoholic fatty liver disease without obesity: the problem to be solved
- Retinol and α-tocopherol in morbid obesity and nonalcoholic fatty liver disease
- Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease
- Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides
- Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin …
- A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity
- Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes
- Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort
- Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease
- Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice
- The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity
- Per-and polyfluoroalkyl substances and obesity, type 2 diabetes and non-alcoholic fatty liver disease: a review of epidemiologic findings
- Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults
- obesity as the common soil of non‐alcoholic fatty liver disease and diabetes: role of adipokines
- Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non‐alcoholic fatty liver disease
- Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice
- obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study
- Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical …
- Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians
- Intimate association of visceral obesity with non‐alcoholic fatty liver disease in healthy A sians: A case‐control study
- Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver by maternal obesity
- Associations among the degree of nonalcoholic fatty liver disease, metabolic syndrome, degree of obesity in children, and parental obesity
- The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study …
- Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents
- obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver
- obesity, fatty liver and liver cancer
- Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease
- Gut microbiota and clinical disease: obesity and nonalcoholic fatty liver disease
- The potential role of iron and copper in pediatric obesity and nonalcoholic fatty liver disease
- Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A United Kingdom population-based cohort …
- KLF10 deficiency in CD4+ T cells triggers obesity, insulin resistance, and fatty liver
- Effect of taurine on the fatty liver of children with simple obesity
- Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity
- Fibrogenesis in fatty liver associated with obesity and diabetes mellitus type 2
- Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center …
- Nonalcoholic fatty liver disease as a comorbidity of childhood obesity
- Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease
- Physical activity is related to fatty liver marker in obese youth, independently of central obesity or cardiorespiratory fitness
- The use of two-dimensional shear wave elastography in people with obesity for the assessment of liver fibrosis in non-alcoholic fatty liver disease
- Distinct effects of calorie restriction and resveratrol on diet-induced obesity and fatty liver formation
- Overweight and obesity status from the prenatal period to adolescence and its association with non‐alcoholic fatty liver disease in young adults: cohort study
- Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults
- The influence of environmental factors on nonalcoholic fatty liver disease and obesity
- Calcium channel blockers as potential therapeutics for obesity-associated autophagy defects and fatty liver pathologies
- Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae
- US time-harmonic elastography: detection of liver fibrosis in adolescents with extreme obesity with nonalcoholic fatty liver disease
- Low levels of alcohol consumption, obesity, and development of fatty liver with and without evidence of advanced fibrosis
- Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver
- Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease
- High fructose feeding induces copper deficiency in Sprague–Dawley rats: a novel mechanism for obesity related fatty liver
- The major green tea polyphenol,(-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat–fed mice
- The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver …
- fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity
- Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity
- Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity
- Metabolically healthy obesity without fatty liver and risk of incident type 2 diabetes: A meta-analysis of prospective cohort studies
- Transcriptome analysis of anti-fatty liver action by Campari tomato using a zebrafish diet-induced obesity model
- Adiponectin and PPAR: a setup for intricate crosstalk between obesity and non-alcoholic fatty liver disease
- … of obesity and alanine aminotransferase levels on the diagnostic accuracy for advanced liver fibrosis of noninvasive tools in patients with nonalcoholic fatty liver …
- Childhood obesity: a risk factor for non-alcoholic fatty liver disease in adolescence
- PNPLA3 I148M variant influences circulating retinol in adults with nonalcoholic fatty liver disease or obesity
- Reduced mitochondrial function in obesity-associated fatty liver: SIRT3 takes on the fat
- Western diet causes obesity-induced nonalcoholic fatty liver disease development by differentially compromising the autophagic response
- Pomegranate flower ameliorates fatty liver in an animal model of type 2 diabetes and obesity
- Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver …
- obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2
- … of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine—recommendations for facing obesity, fatty liver and …
- Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice
- Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus
- Ethnic disparities in adiposity: focus on non-alcoholic fatty liver disease, visceral, and generalized obesity
- … ) and European Association for the Study of obesity (EASO) clinical practice recommendations for the management of non‐alcoholic fatty liver disease: evaluation of …
- The obesity and fatty liver Are Reduced by Plant-Derived Pediococcus pentosaceus LP28 in High Fat Diet-Induced Obese Mice
- Garlic essential oil protects against obesity-triggered nonalcoholic fatty liver disease through modulation of lipid metabolism and oxidative stress
- Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity
- obesity and fatty liver are prevented by inhibition of the aryl hydrocarbon receptor in both female and male mice
- Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease
- Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer
- fatty liver disease and obesity in youth
- Low vitamin D status is associated with nonalcoholic fatty liver disease independent of visceral obesity in Korean adults
- Nonalcoholic fatty liver disease vs. obesity on the risk of erosive oesophagitis
- Antioxidant-upregulated mesenchymal stem cells reduce inflammation and improve fatty liver disease in diet-induced obesity
- Single strain probiotics for dyslipidemia, fatty liver, and obesity: A systematic review and meta-analysis
- A Review of Non-Alcoholic fatty liver Disease: From obesity to liver Transplant
- The roles of obesity and gender on the relationship between metabolic risk factors and non‐alcoholic fatty liver disease in Koreans
- obesity and non-alcoholic fatty liver disease: therapeutic options
- obesity-related nonalcoholic fatty liver: CT features and follow-up studies after low-calorie diet.
- obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease
- obesity in children and adolescents: the relation between metabolic syndrome and non-alcoholic fatty–liver disease
- Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease
- Association between neck circumference and non-alcoholic fatty liver disease in Mexican children and adolescents with obesity
- Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography/Koroner anjiyografi …
- obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
- Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity
- … expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver …
- Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan
- Lactobacillus acidophilus NS1 attenuates diet-induced obesity and fatty liver
- COX‐2‐mediated inflammation in fat is crucial for obesity‐linked insulin resistance and fatty liver
- The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease
- Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome
- Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin
- Nonalcoholic fatty liver disease in Italian children with Down syndrome: prevalence and correlation with obesity-related features
- Translational Research Methods in Diabetes, obesity, and Nonalcoholic fatty liver Disease
- Metabolic health is more important than obesity in the development of nonalcoholic fatty liver disease: a 4-year retrospective study
- Nonalcoholic fatty liver disease and eGFR levels could be linked by the PNPLA3 I148M polymorphism in children with obesity
- Suspected nonalcoholic fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesity
- Connection of nicotine to diet-induced obesity and non-alcoholic fatty liver disease: cellular and mechanistic insights
- obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease
- Anti-obesity and fatty liver-preventing activities of Lonicera caerulea in high-fat diet-fed mice
- Compound C protects mice from HFD-induced obesity and nonalcoholic fatty liver disease
- Abdominal obesity as a predictive factor of nonalcoholic fatty liver disease assessed by ultrasonography and transient elastography in polycystic ovary …
- Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease
- Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study
- obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of fatty liver inflammation in obese mice
- Association of adolescent obesity with nonalcoholic fatty liver disease and related risk factors in Xi’an, China
- Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
- Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease
- Differential impact of weight loss on nonalcoholic fatty liver resolution in a North American cohort with obesity
- Evaluation of Aroclor 1260 exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver disease
- Cutoff points of abdominal obesity indices in screening for non‐alcoholic fatty liver disease in Asians
- Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease
- Effects of mogrosides on high-fat-diet-induced obesity and nonalcoholic fatty liver disease in mice
- Protective effects of licochalcone A ameliorates obesity and non-alcoholic fatty liver disease via promotion of the Sirt-1/AMPK pathway in mice fed a high-fat …
- Metformin prevents fatty liver and improves balance of white/brown adipose in an obesity mouse model by inducing FGF21
- A novel Wistar rat model of obesity-related nonalcoholic fatty liver disease induced by sucrose-rich diet
- Rutin suppresses palmitic acids-triggered inflammation in macrophages and blocks high fat diet-induced obesity and fatty liver in mice
- Administration of small-molecule guanabenz acetate attenuates fatty liver and hyperglycemia associated with obesity
- The roles of the gut microbiota and toll-like receptors in obesity and nonalcoholic fatty liver disease
- Impacts of types and degree of obesity on non-alcoholic fatty liver disease and related dyslipidemia in Chinese school-age children?
- Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men
- Lauric acid versus palmitic acid: effects on adipose tissue inflammation, insulin resistance, and non-alcoholic fatty liver disease in obesity
- An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity
- Effects of Angelica dahurica on obesity and fatty liver in mice
- Causal Relationship of Non-alcoholic fatty liver Disease with obesity and Insulin Resistance.
- Psychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver disease
- Maternal obesity programs offspring non-alcoholic fatty liver disease through disruption of 24-h rhythms in mice
- Nonalcoholic fatty liver disease and cardiovascular risk in children with obesity
- Dietary modification dampens liver inflammation and fibrosis in obesity‐related fatty liver disease
- High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity
- Biochemical predictors of early onset non-alcoholic fatty liver disease in young children with obesity
- Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non‐alcoholic fatty liver disease
- Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density …
- Astaxanthin restricts weight gain, promotes insulin sensitivity and curtails fatty liver disease in mice fed a obesity-promoting diet
- Relationship between nonalcoholic fatty liver disease and vitamin D nutritional status in extreme obesity
- The relationship between aquaglyceroporin expression and development of fatty liver in diet-induced obesity and ob/ob mice
- The risk of abdominal obesity according to the degree of non-alcoholic fatty liver disease in Korean men
- Non-alcoholic fatty liver disease with obesity as an independent predictor for incident gastric and colorectal cancer: a population-based longitudinal study
- Very low-carbohydrate ketogenic diet for the treatment of severe obesity and associated non-alcoholic fatty liver disease: the role of sex differences
- Non-alcoholic fatty liver disease, obesity and other illnesses
- Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation …
- Xanthohumol improves diet-induced obesity and fatty liver by suppressing sterol regulatory element-binding protein (SREBP) activation
- fatty liver in obesity: relation to Doppler perfusion index measurement of the liver
- Soy β-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease
- Serum omentin-1, vaspin, and apelin levels and central obesity in patients with nonalcoholic fatty liver disease
- Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced obesity and fatty liver by Regulating Hepatic Lipogenesis and Cholesterol …
- Early life famine exposure, adulthood obesity patterns and the risk of nonalcoholic fatty liver disease
- Circulating iron levels interaction with central obesity on the risk of nonalcoholic fatty liver disease: a case–control study in Southeast China
- Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity
- … index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance
- obesity and nonalcoholic fatty liver disease associated with adenocarcinoma in patients with lung cancer
- obesity and hepatotoxins as risk factors for fatty liver disease.
- Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk …
- Bitter gourd inhibits the development of obesity-associated fatty liver in C57BL/6 mice fed a high-fat diet
- … between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non‐alcoholic fatty liver …
- Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non‐alcoholic fatty liver disease with none‐to‐mild obesity and liver …
- Surgical management of obesity in patients with morbid obesity and nonalcoholic fatty liver disease
- Is there an association of vascular disease and atherosclerosis in children and adolescents with obesity and non-alcoholic fatty liver disease?
- Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity
- Role of fatty liver in the association between obesity and reduced hepatic insulin clearance
- The Association between Interleukin-6 and Mean Platelet Volume Levels in Central obesity with or without Non-Alcoholic fatty liver Disease
- Non-alcoholic fatty liver in children and adolescents with excess weight and obesity
- Nonalcoholic fatty liver disease of obesity
- Inadequate identification of fatty liver disease, obesity, and metabolic syndrome by family physicians
- Comparison of abdominal obesity and fatty liver and their association with insulin resistance and metabolic syndrome in Chinese adults
- Iron deficiency in patients with nonalcoholic fatty liver disease is associated with obesity, female gender, and low serum hepcidin
- Aerobic training performed at ventilatory threshold improves liver enzymes and lipid profile related to non-alcoholic fatty liver disease in adolescents with obesity
- Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative …
- Outcomes following serial intragastric balloon therapy for obesity and nonalcoholic fatty liver disease in a single centre
- Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease via the modulation of the gut microbiota in rabbits
- Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease
- Loss of hepatic CEACAM1: a unifying mechanism linking insulin resistance to obesity and non-alcoholic fatty liver disease
- Curcumin analog CUR5–8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity
- Hydrodynamic delivery of FGF21 gene alleviates obesity and fatty liver in mice fed a high-fat diet
- fatty liver, insulin resistance, and obesity: relationships with increase in coronary artery calcium over time
- Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice
- Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with obesity and Non-Alcoholic fatty liver Disease
- Non-Alcoholic fatty liver Disease in Cardiac Patients with Overweight and obesity
- The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity
- Protective effect of black relative to white race against non-alcoholic fatty liver disease in patients with severe obesity, independent of type 2 diabetes
- High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling
- The lemon balm extract ALS-L1023 inhibits obesity and nonalcoholic fatty liver disease in female ovariectomized mice
- … Visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity
- … childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity
- Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway
- Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease
- Soya protein β-conglycinin ameliorates fatty liver and obesity in diet-induced obese mice through the down-regulation of PPARγ
- obesity, Smoking, and fatty liver disease
- Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology
- Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome
- Mediation of inflammation, obesity and fatty liver disease by advanced glycation endoproducts.
- Relation of anthropometric obesity and computed tomography measured nonalcoholic fatty liver disease (from the Multiethnic Study of Atherosclerosis)
- Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity
- … adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity
- Overexpression of superoxide dismutase 3 gene blocks high-fat diet-induced obesity, fatty liver and insulin resistance
- … deficiency leads to decreased atherosclerosis, increased white adipose tissue obesity, and non-alcoholic fatty liver disease: a novel mouse model of obesity …
- Hepatic expression of adiponectin receptors increases with non-alcoholic fatty liver disease progression in morbid obesity in correlation with glutathione peroxidase 1
- Effect of obesity on the relationship between nonalcoholic fatty liver disease and glomerular filtration rate
- Beneficial effects of red yeast rice on high-fat diet-induced obesity, hyperlipidemia, and fatty liver in mice
- Whey protein isolate protects against diet-induced obesity and fatty liver formation
- The crosstalk between hypoxia and innate immunity in the development of obesity-related nonalcoholic fatty liver disease
- obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota?
- liver‐specific suppressor of cytokine signaling‐3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity 1
- … Protective Effect of Myristica fragrans Houtt. Extracts Against obesity and Inflammation by Regulating Free fatty Acids Metabolism in Nonalcoholic fatty liver …
- Hepatocyte Notch signaling deregulation related to lipid metabolism in women with obesity and nonalcoholic fatty liver
- Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised …
- Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity
- Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase …
- Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity
- FABP4-Cre mediated expression of constitutively active ChREBP protects against obesity, fatty liver, and insulin resistance
- Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway
- Exploration of a symptoms experience in people with obesity-related nonalcoholic fatty liver disease
- … tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity …
- I148M variant of PNPLA3 increases the susceptibility to non‐alcoholic fatty liver disease caused by obesity and metabolic disorders
- Proteomic analysis to identify differentially expressed proteins between subjects with metabolic healthy obesity and non-alcoholic fatty liver disease
- Therapeutic application of micellar solubilized xanthohumol in a western-type diet-induced mouse model of obesity, diabetes and non-alcoholic fatty liver …
- Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis
- Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice
- Correction of adipocyte secretion disorders in patients with non-alcoholic fatty liver disease with overweight and obesity
- … and microbiota/metabolite-induced epigenetic modifications in the pathogenesis of obesity, metabolic syndrome, type 2 diabetes, and non-alcoholic fatty liver …
- Impact of time-restricted feeding and dawn-to-sunset fasting on circadian rhythm, obesity, metabolic syndrome, and nonalcoholic fatty liver disease
- obesity and nonalcoholic fatty liver disease: metabolic risks and their correction
- Phosphorylation of eIF2α signaling pathway attenuates obesity-induced non-alcoholic fatty liver disease in an ER stress and autophagy-dependent manner
- fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity
- Next-generation sequence analysis of genes associated with obesity and nonalcoholic fatty liver disease-related cirrhosis in extreme obesity
- Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD)
- obesity and fatty liver are ‘grease’for the machinery of hepatic fibrosis
- Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity
- obesity and nonalcoholic fatty liver disease
- Visceral obesity and the risk of Barrett’s esophagus in Japanese patients with non-alcoholic fatty liver disease
- Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertension
- Nutritional strategy to prevent fatty liver and insulin resistance independent of obesity by reducing glucose-dependent insulinotropic polypeptide responses in mice
- Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial
- obesity and nonalcoholic fatty liver disease
- Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option
- Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity
- The Association between SOCS1− 1656G> A Polymorphism, Insulin Resistance and obesity in Nonalcoholic fatty liver Disease (NAFLD) Patients
- Perilipin‐2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra‐hepatocyte actions
- GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance
- Decreased serum neuregulin 4 levels associated with non‐alcoholic fatty liver disease in children with obesity
- Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment
- Microarray technology in the study of obesity and non‐alcoholic fatty liver disease
- Effects of obesity reduction on transient elastography–based parameters in pediatric non-alcoholic fatty liver disease
- The assessment of nonalcoholic fatty liver disease detected by computed tomography in cases with obesity and overweight
- obesity and nonalcoholic fatty liver disease in children
- … of high-fat diet-induced obesity by a mixture of red grape extract, soy isoflavone and L-carnitine: implications in cardiovascular and non-alcoholic fatty liver diseases
- fatty liver and obesity in university students
- Hyperuricemia precedes non-alcoholic fatty liver disease with abdominal obesity moderating this unidirectional relationship: Three longitudinal analyses
- obesity Notches up fatty liver
- Secretion of recombinant interleukin-22 by engineered Lactobacillus reuteri reduces fatty liver disease in a mouse model of diet-induced obesity
- … serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity
- Influence of taurin at the degree of internal obesity and severity of visceral fat dysfunction in patients with non-alcoholic fatty liver disease
- KLB gene polymorphism is associated with obesity and non-alcoholic fatty liver disease in the Han Chinese
- Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity
- … -dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic fatty liver …
- Influence of the interaction between abdominal obesity and hypertriglyceridemia on the development of nonalcoholic fatty liver disease
- Preventing phosphorylation of sterol regulatory element-binding protein 1a by MAP-kinases protects mice from fatty liver and visceral obesity
- … value of serum ferritin in combination with alanine aminotransferase and glucose levels for noninvasive assessment of NAFLD: fatty liver in obesity (FLiO) …
- Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia
- obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women
- A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-. Leiden mice
- Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr …
- Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with …
- Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein–apolipoprotein B-100 in obesity
- Hepatic artery resistance in children with obesity and fatty liver
- Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of …
- Non-alcoholic fatty liver disease, bulb carotid intima-media thickness and obesity phenotypes: results of a prospective observational study
- Effects of long-term synbiotic supplementation in addition to lifestyle changes in children with obesity-related non-alcoholic fatty liver disease
- Meroterpenoid-rich fraction of an ethanolic extract from Sargassum serratifolium alleviates obesity and non-alcoholic fatty liver disease in high fat-fed C57BL/6J mice
- A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell …
- Biallelic mutations in GPD1 gene in a Chinese boy mainly presented with obesity, insulin resistance, fatty liver, and short stature
- Effects of increased systemic inflammation and central obesity on arterial stiffness in patients with nonalcoholic fatty liver disease
- Factors governing development of nonalcoholic fatty liver disease and insulin resistance in obesity
- Effect of a lifestyle intervention in children with obesity and nonalcoholic fatty liver disease
- Antrodia cinnamomea Prevents obesity, Dyslipidemia, and the Derived fatty liver via Regulating AMPK and SREBP Signaling
- Hydrodynamic delivery of interleukin 15 gene promotes resistance to high fat diet-induced obesity, fatty liver and improves glucose homeostasis
- Genetic control of obesity, glucose homeostasis, dyslipidemia and fatty liver in a mouse model of diet-induced metabolic syndrome
- Oat attenuate non-alcoholic fatty liver and obesity via inhibiting lipogenesis in high fat-fed rat
- obesity-linked phosphorylation of SIRT1 by casein kinase 2 inhibits its nuclear localization and promotes fatty liver
- Late effects of childhood cancer treatment: severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood …
- Association of obesity and non-alcoholic fatty liver disease with the fecal calprotectin level in children
- Nonalcoholic fatty liver Disease in Children with obesity
- Serum vitamin D levels are inversely related with non‐alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women
- … reflux symptoms in patients with non-alcoholic fatty liver disease associated with serum levels of triglyceride and cholesterol but not simple visceral obesity
- Genetic polymorphisms associated with obesity and non-alcoholic fatty liver disease in Asian Indian adolescents
- Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: the gut and obesity Asia initiative
- obesity AS A RISK FACTOR FOR NON-ALCOHOLIC fatty liver DISEASE
- Diet-induced alteration of microbiota and development of obesity, nonalcoholic fatty liver disease, and diabetes: study protocol of a prospective study
- Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice
- Mitochondria of mice and men: moderate magnetic fields in obesity and fatty liver
- PREVALENCE OF NONALCOHOLIC fatty liver DISEASE AMONG METABOLIC SYNDROME SUBJECTS & ITS RELATION WITH CENTRAL obesity: A …
- Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease
- Coadministration of epigallocatechin‐3‐gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats
- obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice
- Sechium edule Shoot Extracts and Active Components Improve obesity and a fatty liver That Involved Reducing Hepatic Lipogenesis and Adipogenesis in High-Fat …
- Lipid-rich environment: a key role promoting carcinogenesis in obesity-related non-alcoholic fatty liver disease
- Endocrine status of adolescent girls with non-alcoholic fatty liver disease and obesity
- Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease?
- Genetics of common obesity and nonalcoholic fatty liver disease
- obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease
- Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review
- Low circulating levels of neurotensin in women with nonalcoholic fatty liver disease associated with severe obesity
- Laboratory predictors of the non-alcoholic fatty liver in the persons with abdominal obesity
- The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activity
- Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese
- Association of osteoprotegerin with obesity, insulin resistance and non-alcoholic fatty liver disease in children
- Role of-55CT polymorphism of UCP3 gene on non alcoholic fatty liver disease and insulin resistance in patients with obesity
- Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver
- Raised hepatic free fatty acids in a patient with acute fatty liver after gastric surgery for morbid obesity.
- Nonalcoholic fatty liver: The Association with Metabolic Abnormalities, Body Mass Index and Central obesity—A…
- Algorithm of diagnosis eating disorders and nutritional status in patients with nonalcoholic fatty liver disease, obesity and hypertension
- Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease
- The correlation between obesity-related diseases and non-alcoholic fatty liver disease in women in the pre-operative evaluation for bariatric surgery assessed by …
- fatty liver and obesity: phenotypically correlated but genetically distinct traits in a mouse model of type 2 diabetes
- INFLUENCE OF GASTROINTESTINAL HORMONES ON THE DEVELOPMENT OF obesity AND NON-ALCOHOLIC fatty liver DISEASE IN CHILDREN
- Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children …
- Symposium 1: Overnutrition: consequences and solutions Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome
- … approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity
- Copeptin relates to a fatty liver and measures of obesity in a South African population with mixed ethnicities
- Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the …
- Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil
- Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition …
- Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
- Effects of green coffee extract supplementation on glycemic indexes, leptin, and obesity values in patients with non-alcoholic fatty liver disease
- Host genetic variants in obesity-related nonalcoholic fatty liver disease
- Estimated cardiorespiratory fitness attenuates the impacts of sarcopenia and obesity on non-alcoholic fatty liver in Korean adults
- … of New Opportunities of Pharmacological Protection at the Early Stages of a Non-Alcoholic fatty liver Disease Associated With obesity and Metabolic Syndrome
- Beneficial effects of Omega-3 fatty acids in nonalcoholic fatty liver disease, in child‐hood obesity
- The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women–a hyperinsulinemic euglycemic …
- Effect of seyoeum on obesity, insulin resistance, and nonalcoholic fatty liver disease of high-fat diet-fed C57BL/6 mice
- Nonalcoholic fatty liver Disease in obesity and Type 2 Diabetes
- Clinical observation of patient with obesity and non-alcoholic fatty liver disease case study
- IFN-α-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice
- Effects of knee loading on obesity‐related non‐alcoholic fatty liver disease in an ovariectomized mouse model with high‐fat diet
- SCCA-IgM as a potential biomarker of non-alcoholic fatty liver disease in patients with obesity, prediabetes and diabetes undergoing sleeve gastrectomy
- … between a pediatric health promotion center and a pediatric obesity clinic in detecting metabolic syndrome and non-alcoholic fatty liver disease in children
- Two Cases Reports of Chlid fatty liver with obesity
- Genetic variants associated with obesity and insulin resistance in Hispanic boys with nonalcoholic fatty liver disease
- An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity
- … of Grape Extract, Green Tea Extract and l‐Carnitine Improves High‐fat Diet‐induced obesity, Hyperlipidemia and Non‐alcoholic fatty liver Disease in Mice
- Tissue inhibitors of metalloproteinase-1 and 2 and obesity related non-alcoholic fatty liver disease: is there a relationship?
- Non-alcoholic fatty liver disease is associated with impairment of ejection fraction among individuals with obesity undergoing bariatric surgery: results of a cross …
- Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice
- Investigating the onset of insulin resistance and non-alcoholic fatty liver disease in obesity-induced cardiac dysfunction
- Evaluation of melatonin hormone and nitric oxide levels in non-alcoholic fatty liver patients in relation to obesity and oxidative stress
- obesity and risk of nonalcoholic fatty liver disease: a comparison of bioelectrical impedance analysis and conventionally-derived anthropometric measures
- A low creatinine to body weight ratio predicts the incident nonalcoholic fatty liver disease in nonelderly Chinese without obesity and dyslipidemia: a …
- Estrogen inhibits the effects of obesity and alcohol on mammary tumors and fatty liver
- Virtual reality: new insights regarding the prevalence of nonalcoholic fatty liver disease in children and adolescents with obesity using magnetic resonance imaging
- Improving high-fat diet-induced obesity and fatty liver by adipose tissue targeted delivery of vascular endothelial growth factor-B
- Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C> G) in the development of fatty liver
- Morbid obesity, nonalcoholic fatty liver disease, and weight loss surgery
- A case study on a non-alcoholic fatty liver disease (NAFLD) patient improved by the oriental obesity therapy program
- (S) YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and …
- Sex-associated preventive effects of low-dose aspirin on obesity and non-alcoholic fatty liver disease in mouse offspring with over-nutrition in utero
- Nonalcoholic fatty liver disease in Japanese patients with severe obesity who received laparoscopic Roux-en-Y gastric bypass surgery (LRYGB) in comparison to non …
- Effect of TSH on Non-Alcoholic fatty liver Disease (NAFLD) independent of obesity in children of predominantly Hispanic/Latino ancestry by causal mediation …
- Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity
- Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease
- Chronic intake of moderate fat-enriched diet induces fatty liver and low-grade inflammation without obesity in rabbits
- Impact of Childhood obesity in fatty liver Disease
- Therapeutic potential of interleukin-6 in preventing obesity-and alcohol-associated fatty liver transplant failure
- … glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a …
- Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice
- Factors Governing Development of Non-Alcoholic fatty liver Disease and Insulin Resistance in obesity
- Autologous subcutaneous adipose tissue transplants improve adipose tissue metabolism and reduce insulin resistance and fatty liver in diet‐induced obesity rats
- Impacts of long-term CPAP therapy on fatty liver in male OSA patients with abdominal obesity
- Protective role of pomegranate on fatty liver in obesity: an experimental chemical & histopathological study
- obesity and the pathogenesis of nonalcoholic fatty liver disease
- Insulin-like growth factor binding protein-1, non-alcoholic fatty liver disease, and its relationship with fructose consumption in children with obesity
- Non-alcoholic fatty liver disease associated with obesity: therapeutic opportunities
- Associations of chronic diarrhoea with non-alcoholic fatty liver disease and obesity-related disorders among US adults
- Non-alcoholic and alcoholic fatty liver disease in patients suffering from biliary tract pathology and obesity: clinical and functional aspects
- POCU1b, the n-butanol soluble fraction of polygoni cuspidati rhizoma et radix, attenuates obesity, non-alcoholic fatty liver, and insulin resistance Via …
- Serum γ‐glutamyl transpeptidase levels and hypertension in non‐drinkers: a possible role of fatty liver in the pathogenesis of obesity related hypertension
- Central obesity but not generalised obesity (body mass index) predicts high prevalence of fatty liver (NRFLD), in recently detected untreated, IGT and type 2 diabetes …
- Nonalcoholic fatty liver Disease in Non-Obese Subjects With Abdominal obesity is Associated With A Higher Risk of Advanced Cardiovascular Disease: A 14 Year …
- Ligularia fischeri and its constituent 3, 4-dicaffeoylquinic acid improve obesity-induced nonalcoholic fatty liver disease by regulating lipid metabolism and activating …
- Risk factors such as male sex, smoking, metabolic syndrome, obesity, and fatty liver do not justify screening colonoscopies before age 45
- obesity and liver disease: evaluation of fatty infiltration of the liver using ultrasonic attenuation
- Effect of Litchi chinensis on adipose and hepatic tissues in rats with obesity and non-alcoholic fatty liver disease (NAFLD)
- Furthering the understanding of maternal obesity in nonalcoholic fatty liver disease
- obesity AND NON-ALCOHOLIC fatty liver DISEASE: PN1-02
- The nutraceutical effect of Scenedesmus dimorphus for obesity and nonalcoholic fatty liver disease–linked metabolic syndrome
- Pilot study: asymptomatic hyperuricemia patients with obesity and nonalcoholic fatty liver disease have increased risk of double contour sign
- Hepatopulmonary syndrome caused by hypothalamic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma: a case report
- obesity-Induced Non-alcoholic fatty liver Disease (NAFLD): Role of Hyperhomocysteinemia
- Fat mass and obesity‐associated gene variations are related to fatty liver disease in HIV‐infected patients
- Role of Cyp2b in Unsaturated fatty Acid Metabolism, obesity, and Non-Alcoholic fatty liver Disease
- Prevalence of fatty liver and its association with indices of obesity, liver function and hyperlipidemia among adult males
- A Case Study on a Patient with Non-alcoholic fatty liver Disease (NAFLD) Improved on Sonography by Oriental obesity Therapy
- Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents
- The stomach as an endocrine organ: Expression of key modulatory genes and their contribution to obesity and non-alcoholic fatty liver disease (NAFLD)
- Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage
- Nonalcoholic fatty liver disease can be predicted by retinal vascular changes in patients with obesity without hypertension or diabetes
- Vitamin D deficiency, a noninvasive marker of steatohepatitis in patients with obesity and biopsy proven nonalcoholic fatty liver disease
- Nutrition: A promising route for prevention and management of obesity-related nonalcoholic fatty liver disease
- The association of obesity, metabolic syndrome, diabetes, and cardiovascular disease with nonalcoholic fatty liver disease.
- The potential prophylactic effect of orange peel administration on fatty liver and hyperlipidemia in an animal model of diet induced obesity
- fatty liver disease and other complications of obesity
- Impacts of types and degree of obesity on non-alcoholic fatty liver disease and related dyslipidemia in Chinese school-age children?
- … -induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The fatty liver in obesity study
- Hepatic free fatty acids in alcoholic liver disease and morbid obesity
- J NI. The Risk Factors Of Non-Alcoholic fatty liver Disease Prevalence In obesity With Or Without Diabetes Mellitus
- Predictive value of serum ferritin in combination with alanine aminotransferase and glucose levels for noninvasive assessment of NAFLD: fatty liver in obesity (FLiO) …
- Ptrf transgenic mice exhibit obesity and fatty liver
- Tissue changes in the development of fatty liver by chronic ingestion of sucrose associated with obesity and dyslipidemia in rats
- Dietary sucrose regulates the expression of the Cd36 gene in hepatic tissue of rats with obesity and Non Alcoholic fatty liver Disease (NAFLD)
- The Effect of the Short‐Term Growth Hormone Administration on Non‐Alcoholic fatty liver Disease in Diet‐Induced obesity Models
- Non-alcoholic fatty liver disease in children: a new complication of obesity
- Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men
- Bitter melon powder protects against obesity-associated fatty liver disease by improving colonic microenvironment in rats with high-fat diet-induced obesity
- … /visfatin levels are associated with impaired hepatic mitochondrial function in non-diabetic obese women: a potential link between obesity and non-alcoholic fatty liver …
- fatty degeneration of the liver after intestinal bypass for obesity
- School nutrition program; prevention of obesity and fatty liver in children
- Effects of MGB on obesity-Related Co-Morbidities: Lipids, Hypertension, Non-Alcoholic fatty liver, etc.
- Hepatocellular proliferation and hepatocarcinogen bioactivation in mice with diet-induced fatty liver and obesity
- Effect of obesity on nonalcoholic fatty liver disease in Chinese women with polycystic ovary syndrome
- Diagnosis of fatty liver complicated by simple obesity in children: serum ALT and its correlation with abdominal CT and liver biopsy
- fatty liver disease among other comorbidities requiring early diagnosis in pediatric obesity
- … metabolic syndrome and related disorders: a commentary on: translational research methods in diabetes, obesity, and nonalcoholic fatty liver disease. A focus …
- Gut microbiota interplay between obesity and non alcoholic fatty liver.
- Reduced cardio‐respiratory fitness in obesity with and without nonalcoholic fatty liver disease
- ADVANTAGES OF BIOCHEMICAL METHODS OF DIAGNOSING FIBROSIS IN NON-ALCOHOLIC fatty liver DISEASE IN ADOLESCENTS WITH obesity
- Alcoholic liver disease with nonalcoholic fatty liver disease and obesity
- … and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver …
- Abnormal liver Function Tests and Metabolic Syndrome—Is fatty liver Related to Risks for Atherosclerosis beyond obesity?
- … of the relationship between genetic and environmental risk factors associated with obesity and insulin resistance in South African patients with non-alcoholic fatty liver …
- liver fatty acid-binding protein and obesity
- Relationship between nonalcoholic fatty liver disease and cardiovascular disease in children with obesity
- A case report of adolescent nonalcoholic fatty liver disease (NAFLD) with obesity
- Estimating the Race/Ethnic-Specific Association Between obesity and Type 2 Diabetes, and the Role of Non-Alcoholic fatty liver Disease
- Macrophages and scavenger receptors in obesity‐associated non‐alcoholic liver fatty disease (NAFLD)
- Variations in dietary intake after bypass surgery for obesity. Possible relation to development of fatty liver after jejunoileal bypass.
- Prevalence of obesity, non-alcoholic fatty liver and insulin resistance and their inter relationship among type II diabetic patients attending diabetic centre …
- Analysis of the Correlation Between Ultrasonography Diagnosis fatty liver Grade and Hyperlipidemia and obesity Indicators by Age Groups
- Hepatic cirrhosis secondary to nonalcoholic fatty liver disease in a 12-year-old girl with morbid obesity
- Relationship between serum visfatin level and children and adolescent obesity and non-alcoholic fatty liver disease
- Ultrasound in the diagnostics of fatty liver in obesity
- Physical activity reduce hepatic apoptosis in patients with non-alcoholic fatty liver disease and visceral obesity
- liver fatty acid-binding protein may be a useful marker for non-alcoholic fatty liver disease but obesity is a major concern
- Family history of coronary heart disease is associated with a higher incidence of nonalcoholic fatty liver disease: Central obesity the likely link
- ER stress and autophagy in obesity and nonalcoholic fatty liver disease
- … and parameters of glucose and lipid metabolism at different clinical and morphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity
- Moderation effect of handgrip strength on the associations of obesity and metabolic syndrome with fatty liver in adolescents
- Nonalcoholic fatty liver disease and liver fibrosis in bariatric patients: Tehran obesity treatment study (TOTS)
- Ethnic perception of obesity in fatty liver disease
- Metabolic Changes Underlying Interactions Between obesity and Non‐Alcoholic fatty liver Disease in South Asian Adults
- obesity, non alcoholic fatty liver disease (NAFLD) and coronary artery disease (CAD)
- Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation
- Synthesis and Biological Evaluation of 5-Benzylidenepyrimidine-2,4,6(1H,3H,5H)-trione Derivatives for the Treatment of obesity-Related Nonalcoholic fatty liver …
- Effect of intermittent versus continuous exercise on obesity and fatty liver in rats fed with high-fat diet
- Discovery of a Potent 9‐Deazaxanthine‐based Agent for the Treatment of obesity‐Related Non‐alcoholic fatty liver Disease
- Hypolipidemic and anti-obesity effect of nobiletin and its role in prevention of fatty liver in high fat diet-fed rats.
- obesity, fatty liver and the putative role of the sympathetic nervous system: a review.
- … of the Humoral Component of the Immune System as a Basis for the Progression of Non-Alcoholic fatty liver Disease in Patients with obesity and Concomitant Biliary …
- Mechanisms linking obesity, chronic kidney disease and fatty liver disease
- Bariatric surgery for nonalcoholic fatty liver disease in adolescents with severe obesity
- Prediction of non-alcoholic fatty liver disease by obesity indices
- obesity-related diseases and syndromes: Insulin resistance, type 2 diabetes mellitus, non-alcoholic fatty liver disease, cardiovascular disease, and metabolic …
- liver transplantation in patients with non-alcoholic fatty liver disease and obesity.
- The waist-to-hip ratio is a better obesity index than body mass index and waist circumference for screening for nonalcoholic fatty liver disease in postmenopausal …
- Combined Influence of Insulin Resistance, Overweight/obesity, and fatty liver as Risk Factors for Type 2 Diabetes
- … OF liver TISSUE IN PATIENTS WITH fatty liver DISEASE OF NON-ALCOHOLIC AND ALCOHOLIC ORIGIN ON THE BACKGROUND OF obesity AND …
- The impact of P‐selectin deficiency on obesity‐associated non‐alcoholic fatty liver disease (1116.8)
- Protection against Western diet–induced obesity and hepatic steatosis in liver fatty acid–binding protein knockout mice
- SAT-LB015 Association of Subclinical Hypothyroidism with Nonalcoholic fatty liver in Children with Overweight and obesity
- Prevalence of nonalcoholic fatty liver disease in young patients with abdominal obesity and hypertension
- … -based Structural Equation Model Analysis of Behavioral Intention for Young and Middle-aged Patients with obesity-related Nonalcoholic fatty liver Disease in TCM …
- Electroacupuncture for treatment of simple obesity complicated with fatty liver
- Morbid obesity, non-alcoholic fatty liver disease, metabolic syndrome and bariatric surgery
- Beneficial effects of metformin in diet-induced obesity associated non-alcoholic fatty liver disease
- Non-alcoholic fatty liver Disease in obesity
- Role of PAI-1 in pediatric obesity and nonalcoholic fatty liver disease
- Pharmacological inhibition or genetic ablation of soluble epoxide hydrolase attenuates obesity‐induced nonalcoholic fatty liver disease
- Nonalcoholic fatty liver Disease is More Strongly Associated with Arteriosclerosis than is Abdominal obesity in Health Check-up Examinees
- Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in Chinese young adults
- Severe visceral obesity, fatty liver and diabetes after orchiectomy for prostate cancer
- Microvesicles as biomarkers in diabetes, obesity and non-alcoholic fatty liver disease: current knowledge and future directions
- Relationships between central obesity, fructose intake, and non-alcoholic fatty liver disease in overweight Hispanic adolescents
- Sympathetic Overactivity Contributes to the Pathogenesis of Non‐alcoholic fatty liver Disease During Diet‐induced obesity
- The impacts of obesity and metabolic abnormality on carotid intima-media thickness and non-alcoholic fatty liver disease in children from an inland Chinese …
- Associations between overweight and obesity and risk factors for cardiovascular disease and fatty liver in young offenders serving community orders
- The Intestinal Gut Microbiome as a Biomarker and Driver of obesity and Non-alcoholic fatty liver Disease
- Childhood obesity related to development of fatty liver in children from 6 to 14 in Cochabamba, Bolivia
- Correction: Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural …
- … vaspin level as a predictive indicator in the amelioration of fatty liver and metabolic disturbance in patients with severe obesity after laparoscopic vertical …
- obesity, Inflammation, Nonalcoholic fatty liver Disease, and Hepatocellular Carcinoma
- Increased Prevalence of obesity and Metabolic Syndrome in Patients With Alcoholic fatty liver Disease: 837
- Oxidative stress assessment in different ethnic groups of girls with exogenous constitutional obesity complicated by non-alcoholic fatty liver disease
- Partially hydrogenated vegetable oil containing 5% trans fats when combined with fructose exacerbates obesity and non-alcoholic fatty liver disease in rats
- obesity DEPENDENT METABOLIC SIGNATURES ASSOCIATED WITH NONALCOHOLIC fatty liver DISEASE PROGRESSION: 1304
- Nonalcoholic fatty liver disease in patients with morbid obesity Niealkoholowa stłuszczeniowa choroba wątroby w otyłości olbrzymiej
- … Effect of Brown Rice on Superoxide Dismutase Level and Non-alcoholic fatty liver in an Sprague–Dawley Rat Model of High-fat High-fructose Diet-induced obesity
- The role of vitamin D3 in high fat diet induced fatty liver disease and obesity
- Research progress of stearoyl-CoA desaturase-1 on obesity and non-alcoholic fatty liver disease Abstract
- … obesity: brothers-in-arms: Comment on: PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver …
- Study on the interaction between matrix metalloproteinases gene polymorphism and central obesity in nonalcoholic fatty liver disease
- Animal Models of obesity Characterized by Non-alcoholic fatty liver Disease (NAFLD)
- Wheat bran with unbound ferulic acid does not alter obesity, insulin resistance or fatty liver in obese rats compared to wheat bran with bound ferulic acid (829.22)
- Role of leptin and leptin resistance in non-alcoholic fatty liver disease development in persons with obesity and overweight
- Prevention of obesity-induced nonalcoholic fatty liver disease using grape pomace extract.
- Non-alcoholic fatty liver youth with obesity
- obesity and non-alcoholic fatty liver-therapies in ayurvedic medicines
- obesity and non-alcoholic fatty liver disease
- The clinical features of the non-alcoholic fatty liver disease with chronic kidney disease (chronic pyelonephritis) and obesity
- The effects of mechanical loading on high-fat induced obesity and non-alcoholic fatty liver disease
- Metabolomics reveals that alterations in circulating a-ketoglutarate may be relevant in the assessment of morbid obesity-associated nonalcoholic fatty liver disease
- … spectroscopy (1H-MRS)-based neurometabolite levels and cognitive function in relation to visceral obesity and non-alcoholic fatty liver disease (P14-019-19)
- Neurotensin and nonalcoholic fatty liver disease: beyond obesity
- Study on the correlation of fibroblast growth factor 21 level with the obesity, lipid metabolism and insulin resistance in patients with non-alcoholic fatty liver …
- Maternal obesity Programs Offspring’s Predisposition to Non‐Alcoholic fatty liver Disease and Steatohepatitis
- … from green banana (Musa sp.) attenuates non-alcoholic fat liver accumulation and increases short-chain fatty acids production in high-fat diet-induced obesity …
- … bacterial overgrowth and microbial translocation products in peripheral blood samples and its relationship with nonalcoholic fatty liver disease, in morbid obesity …
- liver electrical impedance tomography for early identification of fatty infiltrate in obesity
- Regulation of obesity and Non-alcoholic fatty liver Diseases by Modulation of the Gut Microbiota Through Inflammasome: its Mechanism and Potential for Clinical …
- … American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver …
- … MELLITUS IN VARIOUS CLINICAL AND MORPHOLOGICAL FORMS OF NONALCOHOLIC fatty liver DISEASE IN PATIENTS WITH ABDOMINAL obesity
- fatty liver and obesity: phenotypically
- Interleukin-15 in the Regulation of obesity and fatty liver Disease
- Correlation between plasma fibroblast growth factor 21 level, obesity and insulin resistance in nonalcoholic fatty liver disease patients.
- S1189 Incorporation of obesity Medicine Into the Care of Patients With Nonalcoholic fatty liver Disease: 1-Year Interim Results
- Aroclor 1260 Exposure Worsens Hepatic And Systemic Inflammation In An Animal Model Of Diet-Induced obesity And Nonalcoholic fatty liver Disease: 682
- Role of fatty liver Disease in Childhood obesity
- Diabetes Mellitus, obesity and Underlying Non Alcoholic fatty liver Disease-Independent Risk Factors for Hepatocellular Carcinoma
- Ultrasound in the diagnostics of fatty liver in obesity
- Increased placental fatty acid transporter 6 and binding protein 3 expression and fetal liver lipid accumulation in a mouse model of obesity in pregnancy
- … INDEX (AHI) PREDICTS NON-ALCOHOLIC fatty liver DISEASE (NAFLD) ACTIVITY SCORE (NAS) IN A COHORT OF PATIENTS WITH MORBID obesity …
- Ultrasound grading of fatty liver and association with obesity
- The Analysis of The efficacy and risk factors in obesity with non-alcoholic fatty liver disease subjects treated with orlistat.
- obesity and Pediatric fatty liver: The Silent Epidemic and Significant Health Problem
- The Influence of Alcohol Consumption on the Association between obesity and fatty liver: 1515
- An epidemiological study of obesity and fatty liver of students in Japan
- Relationships between Parameters of Insulin Sensitivity, obesity and liver Aminotransferases in Patients with Nonalcoholic fatty liver Disease
- P1070 FAILURE TO DIAGNOSE obesity AND SCREEN FOR fatty liver DISEASE IN PEDIATRIC PRACTICE
- liver function in patients with coronary artery disease and nonalcoholic fatty liver disease associated with obesity
- … exercise on serum level of retinol-bonded protein 4, abdominal obesity, and metabolic markers in postmenopausal women with non-alcoholic fatty liver
- Induction method of non-alcoholic fatty liver model in obesity and obesity-resistant rats.
- Identifying Non-Alcoholic fatty liver Disease on Ultrasound and its Correlation with obesity
- 3D Co-Registration of MRI and Histology in a Mouse Model of obesity and Non-Alcoholic fatty liver Disease
- TNFα-INDUCED PHOSPHORYLATION OF C/EBPβ-SERINE-239 IS CRITICAL FOR THE DEVELOPMENT OF obesity AND fatty liver: 63
- HIGH FRUCTOSE FEEDING INDUCES COPPER DEFICIENCY: A NOVEL MECHANISM FOR obesity RELATED fatty liver: 1543
- High dietary fat exacerbates weight gain and obesity in female liver fatty acid binding protein gene-ablated mice
- A comparative study of diet-induced obesity and diet-induced obesity-resistant non-alcoholic fatty liver in rats.
- Visceral obesity as atherogenesis predictor in patients with nonalcoholic fatty liver disease
- Non-alcoholic fatty liver disease: an emerging problem with childhood obesity
- IκB kinase ε: A potential therapeutic target for obesity (and nonalcoholic fatty liver disease)?
- Comorbidities: Non Alcoholic fatty liver in Childhood obesity
- Relationship between insulin resistance, incidence of fatty liver and serum ferritin level in adults with simple obesity
- Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma
- A Role for Recruited Myeloid Cells in obesity Induced fatty liver Disease
- A comparative study of diet-induced obesity and diet-induced obesity-resistant non-alcoholic fatty liver in rats.
- Physical Activity in Nonalcoholic fatty liver Disease in terms of Visceral obesity: 1514
- Intestinal Microbiota-obesity–fatty liver
- Abstract P380: obesity and Non-Alcoholic fatty liver Disease in Children
- Nonalcoholic fatty liver diseases as dramatic consequence of obesity
- obesity and insulin resistance in patients with non-alcoholic fatty liver disease diagnosed by non invasive diagnostic methods
- Non-alcoholic fatty liver disease in a young patient with obesity, hyperandrogenism, postcholecystectomy syndrome and reactive pancreatitis. A clinical case
- … characteristics of the T-and B-cell immunity, depending on the body mass index in the patients with the nonalcoholic fatty liver disease in combination with the obesity
- Central obesity and non-alcoholic fatty liver disease in people living with HIV: a case for targeted
- Polyphenol-rich foods as interventions for obesity and fatty liver disease
- fatty acid synthase (FASN) inhibitors as potential treatment for cancer, obesity, and liver related disorders
- Dietary iron overload induces visceral adipose tissue insulin resistance and hyper-resistinemia, and synergizes with obesity and fatty liver in inducing systemic insulin …
- CD8+ T CELLS REGULATE liver INJURY IN obesity‐RELATED NONALCOHOLIC fatty liver DISEASE
- Research Article Compound C Protects Mice from HFD-Induced obesity and Nonalcoholic fatty liver Disease
- ALGORITHM OF DIAGNOSIS EATING DISORDERS AND NUTRITIONAL STATUS IN PATIENTS WITH NONALCOHOLIC fatty liver DISEASE, obesity …
- Nutritional programming by maternal obesity: insights into the development of non‐alcoholic fatty liver disease
- Prevalence and associated risk factors for obesity and nonalcoholic fatty liver disease in adolescents in Xi’an, Shaanxi province, China.
- Developmental Programming of obesity and fatty liver Disease in Offspring Exposed to Maternal obesity and Dietary Intervention
- Relationship between nonalcoholic fatty liver disease and obesity
- Prediction of course and progression of nonalcoholic fatty liver disease in patients with obesity and pathology of the biliary tract with the help of mathematical modeling …
- … OF CARBOHYDRATE METABOLISM IN PATIENTS WITH TYPE 2 DIABETES IN NONALCOHOLIC fatty liver DISEASE AND obesity (Literature review and own …
- Burden of obesity and Nonalcoholic fatty liver Disease in Helicobacter Infected Pakistani Population
- Causal mediation analysis of Subclinical Hypothyroidism in children with obesity and Non-Alcoholic fatty liver Disease
- Elucidating the mechanism by which the antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease
- The usefulness of methacetin breath test in the initial diagnosis of nonalc oholic fatty liver disease in children with simple obesity-preliminary report.
- … , a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver …
- Aerobic exercises versus low-caloric diet for mild fatty liver patients with central obesity
- Interleukin 15 in nonalcoholic fatty liver disease and obesity
- Effectiveness of taurine and oyster on prevention and treatment of hyperlipidemia and fatty liver with obesity in rats chronically fed with high fat diet
- Association between neck circumference and non-alcoholic fatty liver disease in children and adolescents with obesity
- Success Rate of liver Stiffness Measurement Using Transient Elastography in Non-alcoholic fatty liver Disease Patients with obesity and Its Influencing Factors
- Effect of high sucrose diet on apolipoprotein gene expression in fatty liver with obesity
- ECTOPIC ADIPOSITY OF NON-ALCOHOLIC fatty liver DISEASE IS A STRONG DETERMINANT OF POOR BONE HEALTH IN obesity
- Influencing factor of fatty liver in simple obesity children
- fatty liver, obesity AND HEPATOCELLULAR CANCER: IMPACTS OF UNCOUPLING PROTEIN-2 AND FLUVASTATIN
- Non-alcoholic fatty liver disease (NAFLD) in relation to insulin resistance, metabolic syndrome and obesity.
- Waist circumference triglyceride index (WTI) is useful to predict non-alcoholic fatty liver disease in childhood obesity.
- The state of lipid, carbohydrate metabolism and function of cardiovascular system of patients with non-alcoholic fatty liver disease, overweight and obesity
- DIET INDUCED obesity ALTERS PHASE II HEPATIC XENOBIOTIC METABOLISM: IMPLICATIONS FOR NONALCOHOLIC fatty liver DISEASE: 1915
- The role of MDM2 in the pathogenesis of obesity-induced non-alcoholic fatty liver disease
- Histology of Non-Alcohol fatty liver Disease Among Subjects with Medically Complicated obesity: Does Gender Play a Role?: 514
- Diet‐induced obesity and non‐alcoholic fatty liver disease in TRPV1 null mice
- Ionic Detoxification Reduces obesity and fatty liver in Rats Fed a High-Fat Diet
- Central obesity but not generalised obesity (body mass index) predicts high prevalence of fatty liver (NAFlD), in recently detected untreated, IGT and type 2 …
- obesity is not associated with non-alcoholic fatty liver disease (NAFLD) in HIV-positive gay males
- Dietary Cocoa (Theobroma Cacao) Supplementation Improves obesity-related fatty liver Disease in Mice
- Association between obesity Measures, Inflammatory, Oxidative Stress and Neuronal Injury Markers in Obese Women with Non-Alcoholic fatty liver
- Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics
- Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo AI and …
- Alcohol intake is less important as predictive factors for development of fatty liver disease compared to obesity, impairment of glucose metabolism and dyslipidemia …
- Hepatoprotection of Vitamin E and Green Tea on Oxidative Stress and Inflammatory Responses In Animal Models of obesity-Triggered Nonalcoholic fatty liver …
- liver specific depletion of mitochondrial ATP transporter enhances uncoupled respiration and prevents fatty liver and obesity
- Human Maternal obesity in the Development of Nonalcoholic fatty liver Disease in a Germ-free Mouse Model: Identifying the Role of the Infant Gut …
- obesity and Non-Alcoholic fatty liver Disease: Cause and Effect?
- OP06 Maternal obesity programs offspring innate immune dysregulation in non-alcoholic fatty liver disease
- liver fatty acid binding protein (L-FABP) as a target for the prevention of high fat diet induced obesity and hepatic steatosis
- High g-glutamyl-transferase fractions as new markers to identify non-alcoholic fatty liver disease in childhood obesity
- Study of hepatic leptin and insulin signaling during nonalcoholic fatty liver disease (NAFLD) progression in morbid obesity: 654
- Soy ß-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver
- … effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver axis crosstalk in an” in vivo” model of early obesity and non-alcoholic fatty liver …
- Correlation among fatty liver, obesity and dyslipidemia in staff of government division.
- 1056 Incorporation of obesity Management into the Care of Patients With Nonalcoholic Steatohepatitis: The Yale fatty liver Disease Model
- … OF DETOXIFYING FUNCTION OF THE liver IN PATIENTS WITH HYPERTENSION AND obesity COMBINED WITH NON-ALCOHOLIC fatty liver …
- The intensity of lipid distress syndrome in patients with non-alcoholic fatty liver disease on the background of obesity and chronic kidney disease (chronic …
- Role of the orphan nuclear receptors TR2 and TR4 in the pathophysiology of obesity and non-alcoholic fatty liver disease
- CPAP in fatty liver with obesity without topiramate and MOVE program does not cause sustained weight loss but may results in weight gain-an opinion
- Impact of Maternal obesity on Offspring Bile Acid Homeostasis and Pathologic Progression in Non‐Alcoholic fatty liver Disease
- Metabolism of cyclic GMP in non-alcoholic fatty liver disease in morbid obesity
- … DAMAGE IN PATIENTS WITH NON-ALCOHOLIC fatty liver DISEASE COMBINED WITH METABOLIC SYNDROME DEPENDING ON THE obesity …
- Diagnosis and treatment strategies for fatty liver when obesity coexists with alcohol consumption
- … 5 (Joint Nutrition Society and BAPEN Symposium): Too many pies: metabolic competencies in obesity The importance of fatty liver disease in clinical practice
- obesity and insulin resistance in nonalcoholic fatty liver
- Impact of obesity, Metabolic Syndrome, and Nonalcoholic fatty liver Disease on Systemic Inflammation and Subclinical Atherosclerosis: The Multi-Ethnic Study of …
- Hypolipidemic and anti-obesity effect of nobiletin and its role in prevention of fatty liver in high fat diet-fed rats.
- Maternal obesity promotes offspring non-alcoholic fatty liver disease (NAFLD) through disruption of endoplasmic reticulum homeostasis: 49
- Alcoholic liver disease with nonalcoholic fatty liver disease and obesity.
- PWE-112 Maternal obesity Promotes Offspring Non-Alcoholic fatty liver Disease (Nafld) Through Disruption of Endoplasmic Reticulum Homeostasis
- Relationship between fatty liver and Blood Lipids in Children with Simple obesity
- The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activity
- … of Cell Death-Inducing DFF45-Like Effector (CIDE) Family of Proteins in Patients with obesity Associated Non-Alcoholic fatty liver Disease (NAFLD): 1163
- Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver 1 by maternal obesity 2
- Dual Therapy With Mitochondrial and Cytosolic Antioxidants Improve Non Alcoholic fatty liver Disease (NAFLD) in Diet Induced obesity (DIO) Mouse Model
- Correlation of obesity and Other Factors with Presence of Extra Hepatic Disease among the Patients Presenting with fatty liver
- liver fatty acid composition correlates with body fat and sex in a multigenic mouse model of obesity
- … CARBOHYDRATE METABOLISM IN PATIENTS WITH TYPE 2 DIABETES INNONALCOHOLIC fatty liver DISEASE AND obesity (Literature review and own …
- Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.
- Association of 24 h Behavior Rhythm with Non-Alcoholic fatty liver Disease among American Adults with Overweight/obesity
- Research Article Abdominal obesity as a Predictive Factor of Nonalcoholic fatty liver Disease Assessed by Ultrasonography and Transient Elastography in …
- … fatty liver Disease Differentiates Subpopulations with Higher Risk of Incident Type 2 Diabetes Regardless of Their Metabolic Health and obesity Status: A Nationwide …
- Association of single nucleotide polymorphisms in TNFA, PNPLA3, ADIPOQ and APOC3 genes with obesity and non-alcoholic fatty liver disease in north Indian …
- Non-alcoholic fatty liver disease and childhood obesity.
- Dietary fat and cholesterol in the pathogenesis of obesity and non-alcoholic fatty liver disease
- fatty liver of obesity—An inflammatory disease?
- 1857-P: Modified Mesenchymal Stromal Cells: A Novel and Safe Therapy for Treating Nonalcoholic fatty liver Disease (NAFLD) in obesity and Diabetes
- The impact of severe obstructive sleep apnea and obesity on nonalcoholic fatty liver disease
- Resveratrol stimulation of SIRT1 & exogenous delivery of FGF21 mimics metformin’s ability to alleviate non-alcoholic fatty liver disease caused by diet-induced obesity
- Maternal obesity Promotes Offspring Non-Alcoholic fatty liver Disease (NAFLD) through Disruption of Molecular Circadian Rhythms: 250
- obesity, liver steatosis, and omega-3 fatty acids
- The association of atherosclerosis and combination of fatty liver, insulin resistance and obesity
- … APNEA INFLUENCE THE HISTOLOGY OF NON ALCOHOLIC fatty liver DISEASE IN A COHORT OF PATIENTS WITH MEDICALLY COMPLICATED obesity …
- … of PPAR-g 2 (rs1801282) and ACE (rs4646994) genes on the onset of non-alcoholic fatty liver disease in patients with essential arterial hypertension and obesity
- Prevalence of non alcoholic fatty liver disease in women with morbid obesity
- PILOT STUDY fatty liver AND obesity: MR FAT QUANTIFICATION AND MR ELASTOGRAPHY DURING A VERY LOW-CALORIE-KETOGENIC DIET …
- Hepatic PUFA content impacts fatty liver in mouse models of obesity & diabetes
- … IN THE DEVELOPMENT AND PROGRESSION OF NON-ALCOHOL fatty liver DISEASE AND CHRONIC KIDNEY DISEASE IN PATIENTS WITH obesity
- … . Prevalence of fatty liver and cardiometabolic complications in overweight Indian adolescents: A brief report 11. Patient Information Page on Childhood obesity …
- … in Microrna-155 Leads to Reduced Atherosclerosis, Increased obesity and Nonalcoholic fatty liver Disease–A Novel Mouse Model of Metabolically Healthy obesity
- Nonalcoholic fatty liver disease vs. obesity on the risk of erosive oesophagitis.
- … Therapy with Atorvastatin and Ursodeoxycholic Acid on the Course of Ischemic Heart Disease with Co-Existent Non-Alcoholic fatty liver Disease and obesity
- Ethnic aspects of lipid peroxidation processes in teenagers with obesity and non-alcoholic fatty liver disease
- A comparative study of patients with obesity and non-alcoholic fatty liver disease, fatty liver disease with moderate and severe alcohol intake
- Screening for non-alcoholic fatty liver disease in the obesity epidemic.
- Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.
- Clinical pharmacology of obesity and non-alcoholic fatty liver disease: GRADE evaluation of existing clinical evidence
- Symptoms Experience in Persons with obesity-Related Nonalcoholic fatty liver Disease
- Relation of Anthropometric obesity and Computed Tomography Measured Nonalcoholic fatty liver Disease
- fatty liver Disease in Morbidly Obese Patients in Correlation to obesity Related Co-Morbidities
- Metabolically healthy obesity and the development of nonalcoholic fatty liver disease.
- The Thrombin Inhibitor Dabigatran Inhibits High Fat Diet-induced obesity and fatty liver Disease in Mice
- … EFFECT OF MILD BILIRUBIN ELEVATION IS MASKED BY THE CONFOUNDING FACTOR OF fatty liver AND ABDOMINAL obesity IN THE APPARENTLY …
- … Superfamily Member 1 (Them1) Suppresses Thermogenesis and Contributes to Diet-Induced obesity and Non-Alcoholic fatty liver Disease (NAFLD): 1115
- Impacts of obesity on metabolic profiles in patients with non-alcoholic fatty liver disease.
- Contributions of fatty acid and sterol synthesis to triglyceride and cholesterol secretion by the perfused rat liver in genetic hyperlipemia and obesity.
- Association Between Nonalcoholic fatty liver, Markers of obesity, and Serum Leptin Level in Young Adults
- Higher association of non-alcoholic fatty liver disease with coronary artery calcification than abdominal obesity
- Visceral obesity predicts significant fibrosis in patients with nonalcoholic fatty liver disease.
- Prevalence of fatty liver in Japanese children ages 4 to 12 years old: Relationship to obesity. An epidemiological ultrasonographic survey.
- The genetic background modifies the effects of the obesity mutation,’fatty‘, on apolipoprotein gene regulation in rat liver
- Biochemical Predictors of Early Onset Non-Alcoholic fatty liver Disease in Young Children with obesity
- Long-term adaptation of global transcription and metabolism during induction of obesity and fatty liver in mice
- Changes and significance of serum visfatin levels in obesity and nonalcoholic fatty liver disease.
- Valproic acid obesity and non-alcoholic fatty liver disease in
- Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes.
- Cardiometabolic risk factors in different clinicomorphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity
- Analysis of risk factors in non-alcoholic fatty liver disease in obesity-related hypertension patients.
- Effects of two personalized and hypocaloric dietary interventions in subjects with non-alcoholic fatty liver disease and overweight/obesity after 6 months of follow-up
- Lean-non alcoholic fatty liver disease (NAFLD) with central visceral obesity identifies patients with more severe disease
- Prevalence of liver function abnormalities and predictive markers in Chinese diabetic obesity with nonalcoholic fatty liver diseases undergoing bariatric surgery
- Ptrf transgenic mice exhibit obesity and fatty liver.
- Incidence of obesity in School Children in Rural and Urban Areas in Hokkaido, With a Report of Cases of fatty liver in Obese Children
- obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study.
- Nonalcoholic fatty liver Disease Is Associated with Type 2 Diabetes Mellitus Only in Individuals with Visceral obesity
- Expression of obesity-related gene and forkhead transcription factors in liver of nonalcoholic fatty liver disease rat model
- DEVELOPMENT OF AN ANTI-AP2 MONOCLONAL ANTIBODY TO TREAT obesity RELATED DIABETES AND fatty liver DISEASE
- Association of Serum Adiponectin and Metabolic Syndrome in Children with obesity and Nonalcoholic fatty liver Disease
- Rising obesity rates boosting liver disease risk: the typical patient with nonalcoholic fatty liver disease has a BMI above 30 and insulin resistance.
- Comparison of abdominal obesity and fatty liver and their association with insulin resistance and metabolic syndrome in Chinese adults.
- Effects of mogrosides on high-fat-diet-induced obesity and nonalcoholic fatty liver disease in mice.
- Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity.
- Expression of obesity-related gene and forkhead transcription factors in liver of nonalcoholic fatty liver disease rat model.
- Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic obesity Study.
- … OF INSULIN RESISTANCE ON THE DEVELOPMENT OF NON-ALCOHOLIC fatty liver DISEASE AND ARTERIAL HYPERTENSION IN PATIENTS WITH obesity
- Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia.
- The roles of obesity and gender on the relationship between metabolic risk factors and non-alcoholic fatty liver disease in Koreans.
- Effect of Seyoeum on obesity, insulin resistance, and nonalcoholic fatty liver disease of high-fat diet-fed C57BL/6 mice.
- Transcriptome analysis of anti-fatty liver action by Campari tomato using a zebrafish diet-induced obesity model
- Relationship between the plasma resistin, obesity and insulin resistance in nonalcoholic fatty liver disease patients
- The lemon balm extract ALS-L1023 inhibits obesity and nonalcoholic fatty liver disease in female ovariectomized mice.
- Cutoff points of abdominal obesity indices in screening for non-alcoholic fatty liver disease in Asians.
- obesity and incidence of diabetes: effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver.
- Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease.
- Ionic Detoxification Reduces obesity and fatty liver in Rats Fed a High-Fat Diet
- Lactobacillus acidophilus NS1 attenuates diet-induced obesity and fatty liver.
- Is the gut the key to obesity?: the involvement of the intestine in obesity, type 2 diabetes mellitus and fatty liver disease in man.
- Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice.
- Protective Efficacy of Caralluma diffusa Methanolic Crude Extract against High-fat Diet (HFD) Induced fatty liver obesity in Albino Wistar Rat
- Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease.
- Calcium channel blockers to ameliorate obesity-associated glucose intolerance and fatty liver pathologies
- Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women.
- Differences of lifestyle behaviors between non-obese and obese non-alcoholic fatty liver disease; beyond visceral obesity and metabolic syndrome
- liver dysfunction following small-bowel bypass for obesity: nonoperative treatment of fatty metamorphosis with parenteral hyperalimentation
- A genomic and proteomic study of obesity-related non-alcoholic fatty liver disease (NAFLD)
- MATERNAL obesity PROGRAMS OFFSPRING INNATE IMMUNE DYSREGULATION IN NON-ALCOHOLIC fatty liver DISEASE: 1667
- Risk factors such as male sex, smoking, metabolic syndrome, obesity, and fatty liver do not justify screening colonoscopies before age 45.
- Sex hormone-binding globulin is more than a sex steroid carrier: a New therapeutic target against obesity and non-alcoholic fatty liver disease
- THE ASSOCIATION OF ANTHROPOMETRIC obesity MEASURES WITH CT-MEASURED NON-ALCOHOLIC fatty liver DISEASE IN THE MULTI-ETHNIC …
- Discovery of a potent 9-deazaxanthine-based agent for the treatment of obesity-related non-alcoholic fatty liver disease.
- Clinical and biochemical characteristics in type 2 diabetes mellitus with visceral obesity and nonalcoholic fatty liver disease
- Treatment of non-alcoholic fatty liver disease: an interpretation of the European clinical guidelines for obesity, type 2 diabetes, and digestive disease
- Hypothalamic orexin prevents obesity and non-alcoholic fatty liver disease in mice fed high fat diet
- Beneficial effects of red yeast rice on high-fat diet-induced obesity, hyperlipidemia, and fatty liver in mice.
- Soya protein β-conglycinin ameliorates fatty liver and obesity in diet-induced obese mice through the down-regulation of PPARγ.
- fatty liver, REGIONAL obesity AND TYPE 2 DIABETES MELLITUS
- Obeticholic Acid Ameliorates Non-Alcoholic fatty liver Disease by Improving Metabolic Profile in Dietary obesity, but Not in Obese, Diabetic FOZ/FOZ Mice
- Sechium edule shoot extracts and active components improve obesity and a fatty liver that involved reducing hepatic lipogenesis and adipogenesis in high-fat-diet …
- A combination of grape extract, green tea extract and L-carnitine improves high-fat diet-induced obesity, hyperlipidemia and non-alcoholic fatty liver disease in mice.
- … of high-fat diet-induced obesity by a mixture of red grape extract, soy isoflavone and l-carnitine: implications in cardiovascular and non-alcoholic fatty liver diseases.
- fatty acid composition of liver and adipose tissue lipids in Wistar rats with fat diet‐induced obesity
- Mechanisms of non-alcoholic fatty liver disease development in patients with arterial hypertension and obesity depending on genetic predictors
- COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
- State of platelet-vessel hemostasis in patients with hypertension, abdominal obesity and nonalcoholic fatty liver disease
- INTERLEUKIN 15 IN PATHOGENESIS OF NON-ALCOHOLIC fatty liver DISEASE IN PATIENTS WITH obesity
- obesity-associated steatotic liver exhibits aberrant or altered sphingolipid composition and preferentially accumulates ceramide species containing long chain …
- … CHARACTERISTICS OF CYTOKINE REGULATION AND COOPERATION IN NONALCOHOLIC fatty DISEASE OF THE liver WITH UNDERLYING obesity
- Effects of Maresin 1, an omega-3 fatty acid-derived lipid mediator, on adipose tissue and liver function in obesity
- Specific modulation of hepatic estrogen receptor alpha prevents fatty liver but also obesity and insulin resistance induced by a high fat diet in mice
- Background pathological data in high-fat diet induced obesity mouse and relation to non-alcoholic fatty liver disease
- … acid desaturase indices in rats: Associations between plasma, liver and adipose tissue lipid fractions and the effects of a high-fat diet and diet-induced obesity
- Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo AI and …
- … and mitochondrial glycerol-3-phosphate dehydrogenase in the liver is linked to enhanced fatty acid oxidation in Lou/C, a rat strain resistant to obesity
- Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation.
- Studies on the relationship between obesity, and the metabolic abnormalities of carbohydrate and free fatty acids in patients with liver cirrhosis.
- … GEOMETRY AND MORTALITY PREDICTION BY DIFFERENT INDEXATION METHODS FOR LEFT VENTRICULAR MASS BY obesity STATUS IN 47,865 …
- Non-alcoholic fatty liver disease and childhood obesity
- Management of obesity and nonalcoholic fatty liver disease: a literature review
- Relationship between obesity related indicators and non-alcoholic fatty liver disease in children: a systematic review and meta-analysis
- Impact of obesity in Non-Alcoholic fatty liver Disease
- Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity
- Nonalcoholic fatty liver disease and obesity: an obesity medicine association (OMA) clinical practice statement (CPS) 2022
- Effects of obstructive sleep apnea on non-alcoholic fatty liver disease in patients with obesity: a systematic review
- Anti-obesity medications for the management of nonalcoholic fatty liver disease
- Nonalcoholic fatty liver disease in children with obesity: narrative review and research gaps
- Impact of obesity on liver function tests: is nonalcoholic fatty liver disease the only player? A review article
- Does the mediterranean diet have any effect on lipid profile, central obesity and liver enzymes in non-alcoholic fatty liver disease (NAFLD) subjects? a …
- Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease
- fatty liver Disease in Patients with Prediabetes and Overweight or obesity
- Non-alcoholic fatty liver disease: relation to juvenile obesity, lipid profile, and hepatic enzymes
- obesity and nonalcoholic fatty liver disease
- The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease
- Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques
- Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China
- Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease
- Association between metabolically healthy obesity and non-alcoholic fatty liver disease
- obesity modifies the performance of fibrosis biomarkers in nonalcoholic fatty liver disease
- Association between Mediterranean Diet and fatty liver in Women with Overweight and obesity
- Nonalcoholic fatty liver disease in children with obesity–observations from one clinical centre in the Western Pomerania region
- The impact of vitamin D in non-alcoholic fatty liver disease: a cross-sectional study in patients with morbid obesity
- Quality of life and coping in nonalcoholic fatty liver disease: Influence of diabetes and obesity
- Dietary fiber‐derived short‐chain fatty acids: A potential therapeutic target to alleviate obesity‐related nonalcoholic fatty liver disease
- Depression and increased risk of non-alcoholic fatty liver disease in individuals with obesity
- Clinical Classification of obesity and Implications for Metabolic Dysfunction-Associated fatty liver Disease and Treatment
- The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease
- Associations between abdominal obesity indices and nonalcoholic fatty liver disease: Chinese visceral adiposity index
- The use of very low‐calorie diets in subjects with obesity complicated with nonalcoholic fatty liver disease: A scoping review
- Bariatric surgery reduces cancer risk in adults with nonalcoholic fatty liver disease and severe obesity
- The potential of Lamiaceae herbs for mitigation of overweight, obesity, and fatty liver: studies and perspectives
- Acetaminophen-induced hepatotoxicity in obesity and nonalcoholic fatty liver disease: a critical review
- Correlation between anthropometric measurements and non-alcoholic fatty liver disease in individuals with obesity undergoing bariatric surgery: cross-sectional study
- Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome
- Gender differences in the relationships among metabolic syndrome and various obesity-related indices with nonalcoholic fatty liver disease in a Taiwanese …
- Body composition, phenotype and central obesity indices in Egyptian women with non-alcoholic fatty liver disease
- Hepatocyte mitochondrial dynamics and bioenergetics in obesity-related non-alcoholic fatty liver disease
- Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study
- Metabolically healthy obesity and risk of non‐alcoholic fatty liver disease severity independent of visceral fat
- Assessment of lifestyle factors helps to identify liver fibrosis due to non-alcoholic fatty liver disease in obesity
- Sarcopenic obesity in Non-Alcoholic fatty liver Disease—The Union of Two Culprits
- Hypertension and histopathology severity of non-alcoholic fatty liver disease among adults with obesity: a cross-sectional study
- Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the liver (AISF), the Italian Society of …
- Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver
- Association of bariatric surgery with cardiovascular outcomes in adults with severe obesity and nonalcoholic fatty liver disease
- Review of paediatric obesity and non‐alcoholic fatty liver disease—A focus on emerging non‐pharmacologic treatment strategies
- Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease
- Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity
- Nonalcoholic fatty liver disease and obesity
- Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease
- Serum concentration of fatty acids in children with obesity and nonalcoholic fatty liver disease
- What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?
- Loss of TRIM67 attenuates the progress of obesity-induced non-alcoholic fatty liver disease
- Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: Insights from the general population
- Uric acid versus metabolic syndrome as markers of fatty liver disease in young people with overweight/obesity
- Microvesicular steatosis in individuals with obesity: a histological marker of non-alcoholic fatty liver disease severity
- Prevalence and clinical significance of autoantibodies in children with overweight and obesity with nonalcoholic fatty liver disease
- Associations among adipose tissue immunology, inflammation, exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease
- Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity
- Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: evidence from mediation analysis
- Association of visceral fat obesity, sarcopenia, and myosteatosis with non-alcoholic fatty liver disease without obesity
- Risk and protective factors of non‐alcoholic fatty liver disease in paediatric obesity: A nationwide nested case–control study
- Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
- Accuracy of ultrasound diagnosis of nonalcoholic fatty liver disease in patients with classes II and III obesity: A pathological image study
- Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases
- Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesity
- Risk stratification for sarcopenic obesity in subjects with nonalcoholic fatty liver disease
- obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
- Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease
- Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease
- The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM)
- Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
- Changes in the prevalences of obesity, abdominal obesity, and non-alcoholic fatty liver disease among Korean children during the COVID-19 outbreak
- Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity
- A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver …
- Growth hormone administration improves nonalcoholic fatty liver disease in overweight/obesity: a randomized trial
- Prebiotic inulin as a treatment of obesity related nonalcoholic fatty liver disease through gut microbiota: a critical review
- Nonalcoholic fatty liver disease and continuous metabolic syndrome in adolescents with overweight/obesity
- A systems biology approach to study non-alcoholic fatty liver (NAFL) in women with obesity
- Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease
- Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity
- Waist-to-hip ratio and inflammatory parameters are Associated with risk of non-alcoholic fatty liver disease in patients with morbid obesity
- Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease
- Effects of different green teas on obesity and non-alcoholic fatty liver disease induced by a high-fat diet in mice
- … glucose-body mass index and triglyceride glucose-waist circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight/obesity
- Loss of immunity-related GTPase GM4951 leads to nonalcoholic fatty liver disease without obesity
- Effect of growth hormone therapy on liver enzyme and other cardiometabolic risk factors in boys with obesity and nonalcoholic fatty liver disease
- Dietary fiber intake and non-alcoholic fatty liver disease: The mediating role of obesity
- Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non‐alcoholic fatty liver disease and metabolic dysfunction
- Tomatidine ameliorates obesity-induced nonalcoholic fatty liver disease in mice
- obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease
- Hidden Complication of obesity and Diabetes: Is It Time to Put More Focus on fatty liver?
- Pediatric obesity-related non-alcoholic fatty liver disease: waist-to-height ratio best anthropometrical predictor
- SLC6A14 deficiency is linked to obesity, fatty liver, and metabolic syndrome but only under conditions of a high-fat diet
- Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity
- A model incorporating serum alkaline phosphatase for prediction of liver fibrosis in adults with obesity and nonalcoholic fatty liver disease
- Nonalcoholic fatty liver disease in young children with obesity
- Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity
- Role of fatty acid transport protein 4 in metabolic tissues: insights into obesity and fatty liver disease
- Theabrownin inhibits obesity and non-alcoholic fatty liver disease in mice via serotonin-related signaling pathways and gut-liver axis
- Associations of serum fatty acid proportions with obesity, insulin resistance, blood pressure, and fatty liver: the cardiovascular risk in Young Finns Study
- Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study
- Association between sarcopenic obesity status and nonalcoholic fatty liver disease and fibrosis
- Endoscopic sleeve gastroplasty—Minimally invasive treatment for non-alcoholic fatty liver disease and obesity
- Trends in prediabetes and non-alcoholic fatty liver disease associated with abdominal obesity among Korean children and adolescents: based on the Korea …
- The challenging role of micro-RNAs in non-alcoholic fatty liver disease in children with obesity: is it time for a new era?
- Cardiovascular outcomes and mortality after bariatric surgery in patients with nonalcoholic fatty liver disease and obesity
- … predicts the development of Nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices?
- Gender differences in the risk for incident non-alcoholic fatty liver disease according to the transition of abdominal obesity status: A 16-year cohort study
- Evaluation of liver Metabolism Biomarkers in Metabolic Associated fatty liver Disease According to obesity Phenotype
- Association of maternal obesity and gestational diabetes mellitus with overweight/obesity and fatty liver risk in offspring
- Frequency Of Occurrence of NonAlcoholic fatty liver Heptoses in Patients Without obesity
- Echinocystic acid prevents obesity and fatty liver via interacting with FABP1
- Role of branched-chain amino acid metabolism in type 2 diabetes, obesity, cardiovascular disease and non-alcoholic fatty liver disease
- Gut microbiota in obesity and nonalcoholic fatty liver disease
- Serum uric acid is a mediator of the association between obesity and incident nonalcoholic fatty liver disease: A prospective cohort study
- … combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver …
- obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated …
- Association between sarcopenic obesity and nonalcoholic fatty liver disease and fibrosis detected by Fibroscan
- Non‐alcoholic fatty liver disease mediates the effect of obesity on arterial hypertension
- A prediction model of the incidence of nonalcoholic fatty liver disease with visceral fatty obesity: a general population-based study
- Lower circulating leptin levels are related to non-alcoholic fatty liver disease in children with obesity
- Cross-tissue omics analysis discovers ten adipose genes encoding secreted proteins in obesity-related non-alcoholic fatty liver disease
- … AND CARBOHYDRATE METABOLISM IN PATIENTS WITH NON-ALCOHOLIC fatty liver DISEASE ON THE BACKGROUND OF ABDOMINAL obesity
- Impact of weight reduction on thyroid function and nonalcoholic fatty liver among Egyptian adolescents with obesity
- GATA3 as an immunomodulator in obesity-related metabolic dysfunction associated with fatty liver disease, insulin resistance, and type 2 diabetes
- Models to predict non-alcoholic fatty liver disease linked to obesity in Morocco
- Relation of serum irisin levels to obesity and non-alcoholic fatty liver disease
- Treatment of obesity and metabolic-associated fatty liver disease with a diet or orlistat: a randomized controlled trial
- Ramulus Mori (Sangzhi) Alkaloids Alleviate High-Fat Diet-Induced obesity and Nonalcoholic fatty liver Disease in Mice
- Substantiation of approaches to the correction of lipid metabolism disorders and non-alcoholic fatty liver disease in children with exogenous obesity
- Identification of Hepatic Dendritic Cells in liver Biopsies in Patients with Metabolic Dysfunction-Associated fatty liver Diseas (MAFLD) and obesity
- The association of sarcopenia and visceral obesity with lean nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus
- Combination therapy of metformin and p-coumaric acid mitigates metabolic dysfunction associated with obesity and nonalcoholic fatty liver disease in high-fat diet …
- Polygonatum sibiricum polysaccharides protect against obesity and non-alcoholic fatty liver disease in rats fed a high-fat diet
- Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer’s disease and myocardial infarction
- Corn peptides improved obesity-induced non-alcoholic fatty liver disease through relieving lipid metabolism, insulin resistance and oxidative stress
- The association between different obesity phenotypes and liver fibrosis scores in elderly individuals with fatty liver in Taiwan
- Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity-and inflammation-prone gut microbiome signature
- Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1
- Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models
- Soluble Polysaccharide Derived from Laminaria japonica Attenuates obesity-Related Nonalcoholic fatty liver Disease Associated with Gut Microbiota …
- The relationship between lipid profile and non-alcoholic fatty liver disease in children and adolescents with obesity
- Walnut green husk polysaccharides prevent obesity, chronic inflammatory responses, nonalcoholic fatty liver disease and colonic tissue damage in high-fat diet fed …
- Evaluation of Six Noninvasive Methods for the Detection of Fibrosis in Chinese Patients with obesity and Nonalcoholic fatty liver Disease
- Combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial
- obesity and non-alcoholic fatty liver disease: cardiometabolic risks and their correction
- Expression of STING in Women with Morbid obesity and Nonalcoholic fatty liver Disease
- fatty liver/Adipose Tissue Dual‐Targeting Nanoparticles with Heme Oxygenase‐1 Inducer for Amelioration of obesity, obesity‐Induced Type 2 Diabetes, and …
- Obstructive sleep apnea syndrome risk in patients with non-alcoholic fatty liver disease is associated with obesity and presence of Nash
- obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study
- GP73 is a TBC-domain Rab GTPase-activating protein contributing to the pathogenesis of non-alcoholic fatty liver disease without obesity
- Features of arterial hypertension combined with obesity according to non-alcoholic fatty liver disease (steatosis and steatohepatitis)
- A case report of nonalcoholic fatty liver disease with obesity and dyslipidemia
- The roles of type 2 diabetes and obesity in disease activity and progression of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
- Preventive effects of different black and dark teas on obesity and non-alcoholic fatty liver disease and modulate gut microbiota in high-fat diet fed mice
- … Radix et Rhizoma Attenuates the Progress of obesity-Induced Non-Alcoholic fatty liver Disease through Modulating Intestinal Microbiota-Related Gut–liver …
- Gut microbiota modulation as an alternative in the management of non-alcoholic fatty liver disease and obesity
- Prevalence of overweight/obesity and its relationship with metabolic syndrome and fatty liver index in adult patients with type 1 diabetes. A Brazilian …
- Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease
- Associations between abdominal obesity indices and pathological features of non‐alcoholic fatty liver disease: Chinese visceral adiposity index
- Benefits of physical exercise as approach to prevention and reversion of non-alcoholic fatty liver disease in children and adolescents with obesity
- Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease
- obesity as an Additional Risk Factor for Thrombogenic Changes in Hemostasis in Hypertensive Patients with Non-Alcoholic fatty liver Disease
- Improvement of obesity-induced fatty liver disease by intermittent hypoxia exposure in a murine model
- obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease
- Protective effect and mechanism of lactoferrin combined with hypoxia against high-fat diet induced obesity and non-alcoholic fatty liver disease in mice
- Age‐dependent effects of diabetes and obesity on liver‐related events in non‐alcoholic fatty liver disease: Subanalysis of CLIONE in Asia
- Lutein ameliorates high‐fat diet‐induced obesity, fatty liver, and glucose intolerance in C57BL/6J mice
- Dexmedetomidine ameliorates high‐fat diet‐induced nonalcoholic fatty liver disease by targeting SCD1 in obesity mice
- Screening patterns of nonalcoholic fatty liver disease in children with obesity in Canadian primary care: A cross-sectional study
- … scores based on fatty liver index, magnetic resonance imaging and lipidomic for a nutrigenetic personalized management of NAFLD: The fatty liver in obesity …
- Effect of semaglutide on fatty liver disease biomarkers in patients with diabetes and obesity
- Metabolic Dysfunction–Associated fatty liver Disease (MAFLD) and Thyroid Function in Childhood obesity: A Vicious Circle?
- Sarcopenic obesity in non-alcoholic fatty liver disease
- NON-ALCOHOLIC fatty liver DISEASE IN obesity AND ALSTRÖM SYNDROME, AN ULTRA-RARE GENETIC MODEL FOR METABOLIC DISEASE
- Effect of Ayurveda interventions in non-alcoholic grade II fatty liver associated with obesity–A case report
- Pinch loss ameliorates obesity, glucose intolerance, and fatty liver by modulating adipocyte apoptosis in mice
- Growth differentiation factor 15 (GDF15) is associated with non-alcoholic fatty liver disease (NAFLD) in youth with overweight or obesity
- The Role of Olfactomedin 2 in the Adipose Tissue–liver Axis and Its Implication in obesity-Associated Nonalcoholic fatty liver Disease
- Visceral fat area to appendicular muscle mass ratio as a predictor for nonalcoholic fatty liver disease independent of obesity
- Analysis of risk factors for non-alcoholic fatty liver disease in hospitalized children with obesity before the late puberty stage
- Antisense oligonucleotide technologies to combat obesity and fatty liver disease
- Male Marfan mice are predisposed to high-fat diet-induced obesity, diabetes, and fatty liver
- Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease
- BMAL1 deletion protects against obesity and non-alcoholic fatty liver disease induced by a high-fat diet
- A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis
- … ASSOCIATED (FTO) RS17817449 GENE POLYMORPHISM WITH INSULIN RESISTANCE AND obesity IN THE PATIENTS WITH NON-ALCOHOLIC fatty liver …
- Risk scores for metabolic dysfunction-associated fatty liver disease in pediatric obesity
- … low-volume interval training improves nonalcoholic fatty liver disease fibrosis score and cardiometabolic health in adults with obesity and metabolic syndrome.
- Chronic intermittent hypoxia exposure alternative to exercise alleviates high-fat-diet-induced obesity and fatty liver
- Unravelling obesity and fatty liver Disease Mechanisms; Insights from Population-Based Omics Studies
- Metabolic impact of MKP-2 upregulation in obesity promotes insulin resistance and fatty liver disease
- KLHL3 deficiency in mice ameliorates obesity, insulin resistance, and nonalcoholic fatty liver disease by regulating energy expenditure
- Fucoxanthin as a Phytochemical Anti-obesity and Antioxidant Remedy in Non-Alcoholic fatty liver Disease: A Systematic Review
- LIFR-α-dependent adipocyte signaling in obesity limits adipose expansion contributing to fatty liver disease
- Pericardial fat, thoracic peri-aortic adipose tissue, and systemic inflammatory marker in nonalcoholic fatty liver and abdominal obesity phenotype
- The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease
- … activator of nuclear factor-Kappa B ligand/receptor activator of nuclear factor-kappa B axis in obesity, type 2 diabetes mellitus, and nonalcoholic fatty liver …
- Noninvasive fibrosis screening in fatty liver disease among vulnerable populations: impact of diabetes and obesity on FIB-4 score accuracy
- Circulating PCSK7 level is independently associated with obesity, triglycerides level and fatty liver index in a general population without medication
- Ramadan fasting model exerts hepatoprotective, anti-obesity, and anti-hyperlipidemic effects in an experimentally-induced nonalcoholic fatty liver in rats
- Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity
- The obesity and nonalcoholic fatty liver disease mouse model revisited: liver oxidative stress, hepatocyte apoptosis, and proliferation
- New murine model of alcoholic hepatitis in obesity-induced metabolic-associated fatty liver disease
- obesity and Non Alcoholic fatty liver Disease in Females in tertiary care Hospital
- Frequency of Different Grades of obesity in Females with Non Alcoholic fatty liver Disease
- Abdomen fat and liver segmentation of CT scan images for determining obesity and fatty liver correlation
- obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients
- Non-alcoholic fatty liver disease and sarcopenia is associated with the risk of albuminuria independent of insulin resistance, and obesity
- obesity, non-alcoholic fatty liver disease, COVID-19: dangerous liaisons
- Identification of New Non-BBB permeable tryptophan hydroxylase inhibitors for treating obesity and fatty liver disease
- A targeted multi-omics approach reveals paraoxonase-1 as a determinant of obesity-associated fatty liver disease
- The incidence of visceral obesity in patients with arterial hypertension and non-alcoholic fatty liver disease
- Is There Any Relationship Between Helicobacter pylori and obesity, Metabolic Syndrome, and Non-alcoholic fatty liver Disease?
- A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity
- Approach to Pediatric obesity and Nonalcoholic fatty liver Disease
- The use of very low‐calorie diets in subjects with obesity complicated with nonalcoholic fatty liver disease: A scoping
- … -like peptide-1 receptor agonists in the treatment of obesity/metabolic syndrome, prediabetes/diabetes and non-alcoholic fatty liver disease—current evidence
- Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver
- Defective FXR-SHP Regulation in obesity Aberrantly Increases miR-802 Expression, Promoting Insulin Resistance and fatty liver
- … Lifestyle intervention improves markers of Nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes and obesity: a retrospective matched …
- The inhibition of inner mitochondrial fusion in hepatocytes reduces non-alcoholic fatty liver and improves metabolic profile during obesity by modulating bile acid …
- Effects of GLP-1-Agonist Liraglutide on Non-alcoholic fatty liver disease and obesity
- Association between alanine aminotransferase as surrogate of fatty liver disease and physical activity and sedentary time in adolescents with obesity
- Improvements in hepatic steatosis, obesity, and insulin resistance in adults with nonalcoholic fatty liver disease after the primary obesity surgery endoluminal 2.0 …
- ENDOTOXINEMIA IN PATIENTS WITH obesity AND NON-ALCOHOLIC fatty liver DISEASE
- Association of C-reactive protein with histological, elastographic, and sonographic indices of non-alcoholic fatty liver disease in individuals with severe obesity
- Adipose-targeted SWELL1 deletion exacerbates obesity-and age-related nonalcoholic fatty liver disease
- Aqueous extract of Artemisia capillaris improves non-alcoholic fatty liver and obesity in mice induced by high-fat diet
- The Weighty Issue of Treating obesity in Patients With Nonalcoholic fatty liver Disease
- Phenolic-rich smoothie consumption ameliorates non-alcoholic fatty liver disease in obesity mice by increasing antioxidant response
- Association between fatty liver disease markers and physical activity and sedentary time in children and adolescents with obesity
- QTL-mapping in the obese Berlin Fat Mouse identifies additional candidate genes for obesity and fatty liver disease
- … Tailored Multistrain Probiotic and Micronutrient Mixture Affects Nonalcoholic fatty liver Disease—Related Markers in Patients with obesity after Mini Gastric …
- Cardiac Structure and Function in Patients With obesity and Non-alcoholic fatty liver Disease
- Effects of Fish Oil Supplementation on Reducing the Effects of Paternal obesity and Preventing fatty liver in Offspring
- Role of genetic modification of the PNPLA3 gene in predicting metabolically unhealthy obesity and metabolic associated fatty liver disease in children
- Pharmacological interventions for obesity and non-alcoholic fatty liver disease: Grade evaluation of existing clinical evidence
- Association between non-alcoholic fatty liver disease and subclinical hypothyroidism in children with obesity
- … in Gadoxetate Disodium-Enhanced liver MRI as an Imaging Biomarker in the Diagnosis of Non-Alcoholic fatty liver Disease in Pediatric obesity
- Non‐alcoholic fatty liver disease prevalence in Australia has risen over 15 years in conjunction with increased prevalence of obesity and reduction in healthy lifestyle
- Nonalcoholic fatty liver Disease Severity Is Related to Plasma Pro-Oxidative Biomarkers Rather Than liver Tissue-Measured Nitrogen Metabolism Biomarkers in …
- Environmental exposure to low-dose perfluorohexanesulfonate promotes obesity and non-alcoholic fatty liver disease in mice fed a high-fat diet
- Prevalence of non-alcoholic fatty liver disease in adolescent boys and its association with obesity and lifestyle factors in rural Tamil Nadu
- Soybean β-conglycinin: structure characteristic, allergenicity, plasma lipid-controlling, prevention of obesity and non-alcoholic fatty liver disease
- obesity and Non-Alcoholic fatty liver Disease: Pathophysiology and Management Focused
- Impact of gastric bypass surgery on the liver fibrosis of patients with extreme obesity and nonalcoholic fatty liver disease in 30-month follow-up
- Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease
- Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism
- Perchlorate exposure does not induce obesity or non-alcoholic fatty liver disease in zebrafish
- Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up …
- … effects of polyphenol enriched complex plants extract on metabolic dysfunctions associated with obesity and related nonalcoholic fatty liver diseases in high …
- … -based association of coronary artery calcification and framingham risk score with non-alcoholic fatty liver disease and abdominal obesity in taiwanese adults …
- obesity and Metabolic Dysfunction-associated fatty liver Disease: Understanding the Intricate Link
- Effects of a Short-Term Meal Replacement Hypocaloric Diet in Subjects with obesity and High fatty liver Index
- Cardiovascular and metabolic risks in patients with obesity and non-alcoholic fatty liver disease
- Deoxyschizandrin ameliorates obesity and non‐alcoholic fatty liver disease: Involvement of dual Farnesyl X receptor/G protein‐coupled bile acid receptor 1 activation …
- NLRP3 Deficiency in Nonimmune Cells Averts obesity-Induced fatty liver Disease
- A significant association of non-obese non-alcoholic fatty liver disease with osteosarcopenic obesity in females 50 years and older
- Low muscle mass is linked with presence of non-alcoholic fatty liver disease irrespective to central obesity: highlights from a prospective epidemiological study in …
- Danning tablets alleviate high fat diet-induced obesity and fatty liver in mice via modulating SREBP pathway
- Combined Amelioration of Prebiotic Resveratrol and Probiotic Bifidobacteria on obesity and Nonalcoholic fatty liver Disease
- … of eating behaviour disorders, anthropometric and physiological indicators in patients with non-alcoholic fatty liver disease on the background of abdominal obesity
- Plasma Adiponectin and Its Correlation with Carotid Intima-Media Thickness in obesity and in Type 2 Diabetes and Nonalcoholic fatty liver Disease
- Maternal obesity accelerated non‑alcoholic fatty liver disease in offspring mice by reducing autophagy
- Daisaikoto improves fatty liver and obesity in melanocortin-4 receptor gene-deficient mice via the activation of brown adipose tissue
- Associations of lipid parameters with non-alcoholic fatty liver disease in type 2 diabetic patients according to obesity status and metabolic goal achievement
- Ziziphus spina‐christi (L.) fortified with Camellia sinensis mediates apoptosis, Notch‐1 signaling, and mitigates obesity‐induced non‐alcoholic fatty liver
- Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver
- Differential metabolic risk factors of early nonalcoholic fatty liver disease in male adolescents with obesity and non-obesity prior to adulthood
- Laparoscopic sleeve gastrectomy alters 1H-NMR-measured lipoprotein and glycoprotein profile in patients with severe obesity and nonalcoholic fatty liver …
- Serum proteome profiling reveals differentially expressed proteins between subjects with metabolically healthy obesity and nonalcoholic fatty liver disease
- … weight-loss intervention on metabolic, ultrasound and anthropometric parameters among patients with obesity and non-alcoholic fatty liver disease: an RCT
- The Effect of Non-Alcoholic fatty liver Disease on Weight Loss and Resolution of obesity-Related Disorders After Bariatric Surgery
- Significance of autoantibody seropositivity in children with obesity and non‐alcoholic fatty liver disease
- Pyridylnidulin exerts anti-diabetic properties and improves non-alcoholic fatty liver disease in diet-induced obesity mice
- … , and the risk of nonalcoholic fatty liver disease in individuals with metabolically healthy overweight or obesity and metabolically unhealthy overweight or obesity
- LepRb+ cell–specific deletion of Slug mitigates obesity and nonalcoholic fatty liver disease in mice
- … Secreted Frizzled-Related Protein 5 mRNA Expression in the Adipose Tissue of Women with Nonalcoholic fatty liver Disease Associated with obesity
- Computed tomography–based gastric volumetry for morbid obesity to assess weight loss and fatty liver change
- The role of mean platelet volume in nonalcoholic fatty liver disease without cardiovascular comorbidities, obesity and diabetes mellitus
- Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR−/− mice
- Deregulation of secreted Frizzled-related protein 5 in nonalcoholic fatty liver disease associated with obesity
- Association of 24 h Behavior Rhythm with Non-Alcoholic fatty liver Disease among American Adults with Overweight/obesity
- … -Binding Protein (LBP) Levels Are Associated with Non-Alcoholic fatty liver Disease (NAFLD) and Adipose Inflammation in Human obesity
- fatty liver disease reverses the obesity paradox in chronic kidney disease stages 3–5: A follow‐up study of NHANES III
- Tilianin protects against nonalcoholic fatty liver disease in early obesity mice
- Non-alcoholic fatty liver disease and obesity among adult donors are major challenges to living-donor liver transplantation: A single-center experience
- Structurally‐engineered fatty acid 1024 (SEFA‐1024) improves diet‐induced obesity, insulin resistance, and fatty liver disease
- Psoas muscle area and paraspinal muscle fat in children and young adults with or without obesity and fatty liver
- In silico profiling of nonsynonymous SNPs of fat mass and obesity-associated gene: possible impacts on the treatment of non-alcoholic fatty liver disease
- Investigating the effects of long-term Aroclor 1260 exposure on fatty liver disease in a diet-induced obesity mouse model
- Comment on Leone et al. Association between Mediterranean Diet and fatty liver in Women with Overweight and obesity. Nutrients 2022, 14, 3771
- Mendelian randomization explores the causal relationships between obesity, diabetes, inflammation and nonalcoholic fatty liver disease
- Non-alcoholic fatty liver Disease in Pediatric obesity
- Relationship of gut microbiota and immunological response in obesity-related non-alcoholic fatty liver disease in children
- Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: fatty liver in obesity (FLiO) Study
- Comment on Leone et al. Association between Mediterranean Diet and fatty liver in Women with Overweight and obesity. Nutrients 2022, 14, 3771
- Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults
- Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease …
- Early menarche is associated with insulin-resistance and non-alcoholic fatty liver disease in adolescents with obesity
- … in pregnant women with non-alcoholic fatty liver disease at the stage of non-alcoholic steatohepatitis with varying degrees of comorbid obesity under the influence of …
- Real-life prevalence of Metabolic Associated fatty liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy
- Relationship between nonalcoholic fatty liver disease and liver fibrosis risk scales with overweight and obesity scales in 219,477 spanish workers
- Effects of sleeve gastrectomy and Roux-en-Y gastric bypass on non-alcoholic fatty liver disease in Iranians with morbid obesity
- Hepatopulmonary syndrome: a rare manifestation of cirrhosis in patient with diencephalic obesity and nonalcoholic fatty liver disease after surgery for …
- Value of triglyceride-glucose index combined with obesity index in predicting nonalcoholic fatty liver disease in individuals with obstructive sleep apnea
- Peripheral selective Oxadiazolylphenyl alanine derivatives as tryptophan hydroxylase 1 inhibitors for obesity and fatty liver disease
- Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesity
- Influence of surgical treatment of obesity on the course of nonalcoholic fatty liver disease
- Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease
- Main phylotypes of gut microbiota and their connection with the degree of obesity and the stage of liver fibrosis in patients with non-alcoholic fatty liver disease
- … Protective Effects of Cinnamyl Alcohol Against Hepatic Steatosis, Oxidative and Inflammatory Stress in Nonalcoholic fatty liver Disease Induced by Childhood obesity
- Comparison of obesity-Related Indicators for Nonalcoholic fatty liver Disease Diagnosed by Transient Elastography
- Convergence of endobariatrics and endohepatology for evaluation and treatment of obesity and nonalcoholic fatty liver disease
- The Association Between obesity, Nonalcoholic fatty liver Disease (NAFLD), and Diabetes
- Synthesis and biological evaluation of xanthine derivatives with phenacyl group as tryptophan hydroxylase 1 (TPH1) inhibitors for obesity and fatty liver disease
- Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity
- GLP-1 analogues in the treatment of obesity and non-alcoholic fatty liver disease
- Bariatric surgery improves metabolic and nonalcoholic fatty liver disease markers in metabolically healthy patients with morbid obesity at 5 years
- A cross-sectional analysis of the association between testosterone and biopsy-proven non-alcoholic fatty liver disease in men with obesity
- Non-Alcoholic fatty liver Disease in Children with Overweight and obesity
- Trappc9 deficiency causes obesity and fatty liver disease by constraining dopamine neurotransmission
- Association of Aquaporin 7 and 9 with obesity and fatty liver in db/db Mice
- Deleted genes associated with obesity in Mexican patients diagnosed with nonalcoholic fatty liver disease
- … STEATOSIS, obesity, AND INSULIN-RESISTANCE IN ADULTS WITH NON-ALCOHOLIC fatty liver DISEASE UNDERGOING THE PRIMARY obesity …
- Autoantibodies in children with overweight and obesity with nonalcoholic fatty liver disease: the major role of laboratory technique
- … to Alvarez Stehle, E. Comment on “Leone et al. Association between Mediterranean Diet and fatty liver in Women with Overweight and obesity. Nutrients 2022, 14 …
- Comparative Evaluation of Serum Copeptin in obesity with Non Alcoholic fatty liver Disease.
- Omega-3 use for the treatment of hypertriglyceridemia, low high-density lipoprotein cholesterol levels, and nonalcoholic fatty liver disease in children with obesity
- Usefulness of the triglyceride glucose index to predict nonalcoholic fatty liver disease in children with obesity
- … between nonalcoholic fatty liver disease with visceral fat depots of other localization, metabolic parameters and markers of renal dysfunction in patients with obesity
- Non-Alcoholic fatty liver in obesity with Deteriorating Glucose Control
- Peony seed oil protects against obesity-induced non-alcoholic fatty liver disease via modulation of endoplasmic reticulum stress
- Relationship between plasma 12, 13-diHOME level and nonalcoholic fatty liver disease in patients with type 2 diabetes and obesity.
- … fecal viromes improve blood glucose regulation and alleviates symptoms of metabolic dysfunction-associated fatty liver disease in an obesity male mouse model
- Cardiovascular and liver Diseases in Subjects With Sarcopenic obesity and Nonalcoholic fatty liver Disease
- Reply to letter:“RE: Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study”
- Risk Stratification for Sarcopenic obesity in Nonalcoholic fatty liver Disease
- The association between obesity measurement indices and nonalcoholic fatty liver disease
- SAT356 Predicting Nonalcoholic fatty liver Disease in Adolescent Girls with Polycystic Ovary Syndrome and obesity
- Sarcopenic obesity, the Possible Culprit for Nonalcoholic fatty liver Disease or Fibrosis
- Mediterranean diet is inversely associated to fatty liver index in patients with obesity and low HDL-cholesterol
- Gender difference in association between low muscle mass and risk of non-alcoholic fatty liver disease among Chinese adults with visceral obesity
- Detecting non-alcoholic fatty liver in children with owerweight and obesity.
- Morbid obesity Associated with Non-Alcoholic fatty liver Disease and Complicated by Severe Non-Cirrhotic Portal Hypertension: A Case Report from Rural Kenya
- Developmental programming of Kupffer cells by maternal obesity causes fatty liver disease in the offspring
- Liraglutide with lifestyle intervention in adolescents with overweight/obesity, nonalcoholic fatty liver disease, and type II diabetes mellitus
- A novel PKCβ inhibitor more potent than ruboxistaurin: potential therapeutic tool for obesity and fatty liver disease
- Association between muscle mass deficits and the non-alcoholic fatty liver disease fibrosis score in adults without central obesity
- Non-alcoholic fatty liver disease (NAFLD) and obesity in inflammatory bowel disease (IBD) patients in Gorgan
- Clinical efficacy of laparoscopic sleeve gastrectomy in treatment of obesity associated nonal-coholic fatty liver disease
- liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity
- Study on the effect of vitamin D on obesity and fatty liver induced by monosodium glutamate in male albino rats
- S1453 Weight Loss in Bariatric Surgery Patients Treated at a Novel Clinic Incorporating obesity Medicine for Treatment of Nonalcoholic fatty liver Disease
- Arterial stiffness, high fasting glucose, and fatty liver as predictors for visceral obesity in middle-aged Chinese individuals: a cross-sectional study
- Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in obesity-related fatty liver disease
- Very low-carbohydrate ketogenic diet for the treatment of severe obesity and associated non-alcoholic fatty liver disease: the role of sex differences
- Usefulness of Controlled Attenuation Parameter for Identification and Grading of Nonalcoholic fatty liver Disease in Adolescents with obesity
- Risk Stratification for Sarcopenic obesity in Subjects With Nonalcoholic fatty liver Disease Q1
- … Between Metabolic Dysfunction-Associated fatty liver Disease and Hyperfiltration In Subjects with Prediabetes and Abdominal obesity Without Evidence of Chronic …
- Focal nodular hyperplasia‐like lesion in a girl with obesity and fatty liver
- Validation of Nutritional Ultrasound as a Tool for the Detection of Risk of Non-Alcoholic fatty liver Disease in the Pediatric Population with obesity
- The natural course of liver fibrosis in non-alcoholic fatty liver disease and after chronic hepatitis C cure in patients with normal body weight and obesity
- Association between Dietary fatty Acid Intake and liver Steatosis and Fibrosis in a Sample of Mexican-Origin Hispanic Adults with Overweight or obesity
- TyG index correlation with surrogate measures of visceral obesity, insulin resistance and non-alcoholic fatty liver disease
- … Efficacy of Using Liraglutide for Improving Non-Acoholic fatty liver Disease Condition in Pediatric-Adolescent Population with obesity: Real World Evidence
- Mesenchymal Stromal Cell (MSC) Therapy Improve Nonalcoholic fatty liver Disease (NAFLD) in Long Term high Fat Diet (HFD) Induced obesity (DIO) Mouse
- Markedly Low Prevalence of fatty liver despite obesity in Prader-Willi Syndrome: A Search for Protective Genetic Markers
- Association between obesity profile and non-alcoholic fatty liver by race/ethnicity
- Inhibition of Forebrain Microglia Ameliorates Non‐alcoholic fatty liver Disease During obesity
- … multivariable Mendelian randomization analysis disentangling the causal relations between abdominal obesity, non-alcoholic fatty liver disease and cardiometabolic …
- Ficus Lyrata Bark Extract Alleviates Steatosis in obesity-Induced Non-Alcoholic fatty liver Disease in Rats
- Optimization of early diagnosis of fibrosis in patients with non-alcoholic fatty liver disease with obesity and overweight
- Chronic Transient Hypoxia Alleviates High Fat Diet-Induced obesity and fatty liver in C57 Mice by Upregulating Epinephrine Levels and Activation of AMPK
- Fatal complications after an interrupted gastric bypass operation in a patient with non-alcoholic fatty liver disease and massive obesity: a case report
- A Promising Approach for Preventing of Diet-Induced obesity and fatty liver Using Tetrahydroxanthohumol, A Synthetic Derivative of Xanthohumol
- RE: Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity—an observational study
- 372-OR: Long-Term Outcomes of Metabolic Surgery vs. Medical/Lifestyle Therapy on Nonalcoholic fatty liver Disease in Adults with obesity and Type 2 Diabetes
- B Cell Responses During obesity-Associated Non-Alcoholic fatty liver Disease and Age-Related Decline
- obesity–fatty liver: the role of the pediatrician
- Usе of plant-based drugs in the treatment of nonalcoholic fatty liver disease and obesity
- Relationship between nonalcoholic fatty liver disease and liver fibrosis risk scales with overweight and obesity scales in 219,477 spanish workers
- Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
- TLT-1, a Potential Regulator of Inflammatory Pathogenesis in obesity and Non-Alcoholic fatty liver Disease (NAFLD)
- Cardiovascular pathology in patients with non-alcoholic fatty liver disease with overweight and obesity
- obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver
- Bifidobacterial probiotics protect mice from diet-induced obesity and fatty liver disease
- obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study.
- Relationship between metabolically healthy obesity and the prevalence of non-alcoholic fatty liver disease
- Association between maternal obesity, essential fatty acids and biomarkers of fetal liver function
- Non-alcoholic fatty liver disease (NAFLD) in children with obesity: narrative review and research gaps
- Importance of the Gut-liver Axis on Lipid Metabolism: Implications in the Pathogenesis of obesity-Related Non-Alcoholic fatty liver Disease
- 1348-P: Roux-en-Y Gastric Bypass Prevents obesity-Induced fatty liver by Modulating liver Lipocalin Type Prostaglandin D2 Synthase Expression
- The Correlation of Diagnosed fatty liver and Hematological Examination and obesity Index in Adult Men
- Elevated Plasma Copeptin Levels Identify the Presence and Severity of Nonalcoholic fatty liver Disease in obesity
- The course of chronic kidney disease (chronic pyelonephritis) in patients with non-alcoholic fatty liver disease and obesity
- Impact of gastric bypass surgery on the liver fibrosis of patients with extreme obesity and nonalcoholic fatty liver disease in 30-month follow-up.
- Ionic Detoxification Ameliorates obesity and Reduces fatty liver in Rats Exposed to a High-Fat Diet
- Forebrain microglia involvement in non‐alcoholic fatty liver disease during obesity
- The role of microRNA-802 regulated by the nuclear receptor FXR-SHP cascade in obesity and non-alcoholic fatty liver disease
- Deleterious liver-adipose crosstalk in obesity: Hydroethanolic extract of Lampaya medicinalis Phil.(Verbenaceae) counteracts fatty acid-induced fibrotic marker …
- … implementation of a weight loss intervention pathway for non-alcoholic fatty liver disease patients by advanced practice hepatology providers with obesity …
- … for Early Diagnosis of Kidney Damage in Patients with Type 2 Diabetes Combined with Nonalcoholic fatty liver Disease and obesity Exposed to Covid-19 …
- Corrigendum to ‘Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver.'[European Journal of Internal …
- The diagnostic values of obesity-related indices in nonalcoholic fatty liver disease.
- … with Anthropometric Measurements, Biochemical Parameters and Body Fat Distribution and the Effects of These Variables on fatty liver in Boys with obesity and …
- Characterization of Chinese medicine celastrol and celastrol-loaded biodegradable nanoparticles towards the therapy of obesity and non-alcoholic fatty liver disease
- Hepatic Insulin Resistance Drives Visceral obesity and Non-Alcoholic fatty liver Disease
- Associations between dyspepsia and obesity in non-alcoholic fatty liver disease patients
- Microbiome Relationship of gut microbiota and immunological response in obesity-related non-alcoholic fatty liver disease in children.
- … omega-3 polyunsaturated fatty acids supplementation for liver left lateral section volume reduction in individuals with morbid obesity undergoing bariatric surgery: A …
- Association of fat mass-and obesity-associated gene (FTO) polymorphisms with susceptibility to nonalcoholic fatty liver disease
- obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients
- obesity, non-alcoholic fatty liver disease, and FTO oligonucleotide polymorphism
- INTENSITY OF MECHANISMS OF INTERACTION OF NON-ALCOHOLIC fatty liver DISEASE AND CHRONIC KIDNEY DISEASE AGAINST obesity
- Corrigendum to ‘Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the liver (AISF), the Italian …
- Metabolic fatty liver disease linked to obesity in burkinabè adults.
- Lipid Droplet Accumulating Microglia Involvement In Non-Alcoholic fatty liver Disease During obesity
- Central obesity is an Independent Determinant of Advanced Fibrosis in Lean Patients with Non-alcoholic fatty liver Disease (NAFLD)
- 210-OR: Presence of Type 2 Diabetes (T2D) Affects HDL Particle Proteomic Composition Independently of obesity or fatty liver
- Laparoscopic sleeve gastrectomy in the treatment of obesity with nonalcoholic fatty liver disease
- Correction: Non‑alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the liver (AISF), the Italian Society of …
- obesity, Non-Alcoholic fatty liver Disease and Eating Behavior Disorders
- … of the Italian Association for the Study of the liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of obesity (SIO)”[Dig liver Dis 54 (2022) 170 …
- fatty acid binding protein 4 in obesity related liver disease; from steatosis to cancer progression
- Correction: Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the liver (AISF), the Italian Society of …
- 8-OR: Plasminogen Deficiency Protects against Nonalcoholic fatty liver Disease and Insulin Resistance, but Not Diet-Induced obesity
- Semaglutide in obesity and Non-Alcoholic fatty liver Disease
- … -Like Peptide-1 Receptor Agonists in the Treatment of obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic fatty liver Disease-Current Evidence
- Inhibition of mammalian mtDNA transcription paradoxically activates liver fatty acid oxidation to reverse diet-induced hepatosteatosis and obesity
